Blood Test Biomarkers Guide: 15,000+ Markers | Kantesti AI

Blood Test Biomarker Guide: 15,000+ Markers Analyzed by AI

Our AI platform analyzes 15,000+ blood test biomarkers with 99.84% accuracy. This expert-curated reference guide features 200 essential markers—the most clinically important biomarkers carefully selected from our comprehensive database for your quick reference.

🧬 15,000+ Biomarkers Analyzed 📋 200 Essential Markers Featured 🌍 75+ Languages ✅ Medically Reviewed 🤖 AI-Powered Analysis

This comprehensive biomarker reference guide was authored under the leadership of Dr. Thomas Klein, MD, Chief Medical Officer at Kantesti AI, in collaboration with our distinguished Medical Advisory Board. The content has been reviewed by Prof. Dr. Hans Weber and medically validated by Dr. Sarah Mitchell, MD, PhD.

Dr. Thomas Klein MD, Chief Medical Officer at Kantesti AI, board-certified clinical hematologist and lead author of this biomarker reference guide
Lead Author & Medical Director

Thomas Klein, MD

Chief Medical Officer, Kantesti AI

Dr. Thomas Klein brings over 15 years of expertise in clinical hematology and laboratory medicine to his role as Chief Medical Officer at Kantesti AI. Board-certified in hematology, he specializes in AI-assisted diagnostics and has dedicated his career to improving blood test interpretation accuracy. As CMO, Dr. Klein oversees all clinical validation processes and ensures the medical accuracy of our 2.78 trillion parameter neural network that powers the Kantesti platform. His extensive publication record includes peer-reviewed research on red blood cell indices interpretation, biomarker analysis, and the application of artificial intelligence in laboratory diagnostics.

Prof Dr Hans Weber MD PhD, Senior Medical Advisor at Kantesti AI specializing in hematology research
Co-Author & Reviewer

Prof. Dr. Hans Weber, MD, PhD

Senior Medical Advisor, Kantesti AI

Prof. Dr. Hans Weber is an internationally recognized hematologist whose research focuses on red blood cell morphology and automated blood analysis systems. With over two decades of experience in academic medicine and clinical laboratory science, Dr. Weber serves on our Medical Advisory Board where he contributes to algorithm development and clinical validation protocols. His work has significantly advanced the field of AI-assisted hematological diagnostics.

Dr Sarah Mitchell MD PhD, Chief Medical Advisor for Clinical Pathology at Kantesti AI
Medical Reviewer

Dr. Sarah Mitchell, MD, PhD

Chief Medical Advisor - Clinical Pathology, Kantesti AI

Dr. Sarah Mitchell brings over 20 years of expertise in clinical pathology and laboratory medicine to her role as Chief Medical Advisor at Kantesti AI. Board-certified in both anatomic and clinical pathology, she specializes in diagnostic accuracy assessment and quality assurance. Dr. Mitchell is responsible for overseeing all medical content review, ensuring that every biomarker interpretation meets the highest standards of evidence-based medicine and clinical accuracy.

15,000+
Biomarkers Analyzed
200
Featured in This Guide
99.84%
AI Accuracy Rate
75+
Languages Supported
2M+
Users Worldwide

Complete Blood Count (CBC) Biomarkers

25+ markers

Red Blood Cells (RBC)

CBC

Also known as: Erythrocytes, Red Cell Count

Normal: 4.5-5.5 M/μL (men) | 4.0-5.0 M/μL (women)

Red blood cells carry oxygen from lungs to tissues and return carbon dioxide for exhalation. Each RBC contains hemoglobin, the iron-rich protein that binds oxygen molecules. RBC production occurs in bone marrow and is regulated by erythropoietin hormone from the kidneys.

High Levels: Polycythemia vera, dehydration, chronic hypoxia, lung disease, high altitude
Low Levels: Anemia (iron, B12, folate deficiency), blood loss, bone marrow disorders, chronic kidney disease
Clinical Significance

RBC count is fundamental to diagnosing anemias and polycythemias. Interpret alongside hemoglobin, hematocrit, and red cell indices (MCV, MCH, MCHC, RDW) for accurate diagnosis.

Hemoglobin (Hgb/Hb)

CBC

Also known as: Haemoglobin

Normal: 13.5-17.5 g/dL (men) | 12.0-15.5 g/dL (women)

Hemoglobin is the iron-containing protein within red blood cells that transports oxygen throughout the body. Each hemoglobin molecule contains four heme groups, each binding one oxygen molecule. Also helps transport CO2 and maintain blood pH.

High Levels: Polycythemia, dehydration, COPD, heart disease, smoking, high altitude
Low Levels: Iron deficiency anemia, B12/folate deficiency, chronic bleeding, thalassemia, sickle cell disease
Clinical Significance

Hemoglobin is the primary marker for diagnosing anemia. Low hemoglobin reduces oxygen-carrying capacity causing fatigue, pallor, shortness of breath. Critically low hemoglobin (<7 g/dL) may require blood transfusion.

Hematocrit (HCT)

CBC

Also known as: Packed Cell Volume (PCV), Crit

Normal: 38.3-48.6% (men) | 35.5-44.9% (women)

Hematocrit represents the percentage of blood volume occupied by red blood cells. It provides quick assessment of blood's oxygen-carrying capacity and fluid balance.

High Levels: Dehydration, polycythemia vera, chronic hypoxia
Low Levels: Anemia, overhydration, acute blood loss
Clinical Significance

Hematocrit is approximately three times the hemoglobin value. Elevated hematocrit (>55%) increases blood viscosity and thrombosis risk.

MCV (Mean Corpuscular Volume)

CBC

Also known as: Mean Cell Volume, Average RBC Size, high mcv blood test meaning

Normal: 80-100 fL (femtoliters)

MCV measures the average size of red blood cells in femtoliters. This critical index helps classify anemias into microcytic (MCV<80), normocytic (80-100), and macrocytic (>100). Essential for determining the underlying cause of anemia and guiding treatment.

High MCV (>100): Vitamin B12 deficiency, folate deficiency, alcoholism, liver disease, hypothyroidism
Low MCV (<80): Iron deficiency anemia, thalassemia, chronic disease, sideroblastic anemia, lead poisoning
Clinical Significance

MCV combined with RDW provides powerful diagnostic information. Low MCV with normal RDW suggests thalassemia; low MCV with high RDW indicates iron deficiency.

📖 Read: RDW Blood Test Complete Guide to RDW-CV, MCV & MCHC (2025)

MCH (Mean Corpuscular Hemoglobin)

CBC

Also known as: Mean Cell Hemoglobin, Average Hemoglobin per RBC

Normal: 27-33 picograms (pg)

MCH quantifies the average amount of hemoglobin contained in a single red blood cell, measured in picograms. This index reflects both cell size and hemoglobin content. MCH typically correlates closely with MCV—larger cells contain more hemoglobin.

High MCH: Macrocytic anemias, vitamin B12 deficiency, folate deficiency, liver disease
Low MCH: Iron deficiency anemia, thalassemia, chronic inflammatory conditions
Clinical Significance

Low MCH indicates hypochromic red cells with reduced hemoglobin. When both MCH and MCV are low (hypochromic microcytic anemia), iron studies help differentiate iron deficiency from thalassemia.

📖 Complete MCH & RDW Guide

MCHC (Mean Corpuscular Hemoglobin Concentration)

CBC

Also known as: MCHC bajo en sangre que significa, Hemoglobin Concentration

Normal: 32-36 g/dL

MCHC represents the average concentration of hemoglobin within red blood cells. Unlike MCH which measures total hemoglobin per cell, MCHC reflects hemoglobin density. This marker remains relatively stable and helps identify spherocytosis when elevated or hypochromic conditions when decreased.

High MCHC (>36): Hereditary spherocytosis, autoimmune hemolytic anemia, severe dehydration
Low MCHC (<32): Iron deficiency anemia, thalassemia, sideroblastic anemia, chronic blood loss
Clinical Significance

Low MCHC indicates hypochromic anemia where red cells appear pale under microscopy. MCHC rarely exceeds 36 g/dL due to hemoglobin solubility limits; elevated values suggest spherocytes or technical artifacts.

📖 MCHC Complete Guide with RDW Interpretation

RDW (Red Cell Distribution Width)

CBC

Also known as: RDW-CV, RDW-SD, RDW en sangre, rdw blood test, what is rdw in blood test, rdw cv blood test high

Normal RDW-CV: 11.5-14.5% | RDW-SD: 39-46 fL

RDW measures the variation in size (anisocytosis) among red blood cells. RDW-CV (coefficient of variation) is expressed as percentage, while RDW-SD (standard deviation) is measured in femtoliters. High RDW indicates significant variation in cell sizes, often seen in nutritional deficiencies or mixed anemias.

High RDW: Iron deficiency anemia, vitamin B12 deficiency, folate deficiency, mixed anemias, myelodysplastic syndromes, hemolytic anemia
Normal RDW + Low MCV: Thalassemia trait (cells uniformly small)
Elevated RDW-SD: Combined deficiencies with both small and large cells
Clinical Significance

RDW is crucial for differentiating anemias. Iron deficiency shows high RDW with low MCV, while thalassemia trait shows normal RDW with low MCV. Recent research links elevated RDW to increased cardiovascular mortality and overall mortality risk even in non-anemic patients. What level of RDW is dangerous? RDW above 14.5% warrants investigation.

📖 Featured: RDW Blood Test: Complete Guide to RDW-CV, MCV & MCHC (2025)

White Blood Cells (WBC)

CBC

Also known as: Leukocytes, Total WBC Count

Normal: 4,500-11,000 cells/μL

White blood cells are the cornerstone of your immune system, defending against infections and abnormal cells. Total WBC includes five main types: neutrophils, lymphocytes, monocytes, eosinophils, and basophils—each with distinct immune functions.

High WBC (Leukocytosis): Bacterial infections, inflammation, leukemia, stress, corticosteroids, smoking
Low WBC (Leukopenia): Viral infections, bone marrow suppression, chemotherapy, autoimmune disorders
Clinical Significance

WBC differential identifies which cell types are elevated. Neutrophilia suggests bacterial infection, lymphocytosis indicates viral infection. WBC <4,000 increases infection risk; >30,000 may indicate leukemia.

Neutrophils

CBC

Also known as: Neutrófilos altos, PMNs, Polys, antibiotics for high neutrophils

Normal: 45-70% of WBC (2,500-7,000 cells/μL)

Neutrophils are the most abundant white blood cells, serving as first responders to bacterial infections. These phagocytic cells engulf and destroy bacteria through oxidative bursts. They have a short lifespan (8-12 hours) and are continuously produced at rates exceeding 100 billion cells daily.

Neutrophilia: Bacterial infections, inflammation, tissue necrosis, surgery, stress, corticosteroids
Neutropenia: Viral infections, chemotherapy, radiation, autoimmune disorders, severe sepsis
Clinical Significance

Absolute neutrophil count (ANC) below 1,500 cells/μL defines neutropenia; below 500 (severe neutropenia) creates high infection risk. Antibiotics for high neutrophils may be warranted if bacterial infection is confirmed.

Lymphocytes

CBC

Also known as: Lymphs, T-cells, B-cells, NK cells

Normal: 20-40% of WBC (1,000-4,000 cells/μL)

Lymphocytes include T-cells (cell-mediated immunity), B-cells (antibody production), and Natural Killer cells. They provide targeted responses to specific pathogens and maintain immunological memory.

Lymphocytosis: Viral infections, chronic lymphocytic leukemia, lymphoma
Lymphopenia: HIV/AIDS, immunosuppressive therapy, severe acute illness
Clinical Significance

Lymphocyte counts below 1,000 cells/μL increase infection susceptibility. Persistent lymphocytosis above 5,000 may indicate chronic lymphocytic leukemia.

Monocytes

CBC

Also known as: Monos, Macrophage precursors

Normal: 2-8% of WBC (200-800 cells/μL)

Monocytes are precursors to tissue macrophages. They phagocytose pathogens, present antigens, and orchestrate inflammatory responses, bridging innate and adaptive immunity.

Monocytosis: Chronic infections (TB, endocarditis), autoimmune diseases, malignancies
Clinical Significance

Persistent monocytosis may indicate chronic infection or malignancy. Monocyte count above 1,000 cells/μL lasting over 3 months warrants hematological evaluation.

Eosinophils

CBC

Also known as: Eos, Eosinophil Count

Normal: 1-4% of WBC (100-400 cells/μL)

Eosinophils combat parasitic infections and mediate allergic inflammatory responses. They contain cytotoxic proteins that damage parasites but can also cause tissue damage in allergic conditions.

Eosinophilia: Allergies, asthma, parasitic infections, drug reactions, autoimmune diseases
Clinical Significance

Mild eosinophilia (500-1,500/μL) often reflects allergies. Hypereosinophilia (>5,000/μL) risks organ damage and requires urgent evaluation.

Basophils

CBC

Also known as: Basos, Basophil Count

Normal: 0.5-1% of WBC (0-100 cells/μL)

Basophils are the least common circulating white blood cells. They contain histamine and heparin, contributing to allergic reactions and inflammation.

Basophilia: Allergic reactions, chronic myeloid leukemia, polycythemia vera, hypothyroidism
Clinical Significance

Persistent basophilia above 200 cells/μL may indicate myeloproliferative disorder, especially chronic myeloid leukemia.

Platelets (PLT)

CBC

Also known as: Thrombocytes, Platelet Count

Normal: 150,000-400,000/μL

Platelets are small cell fragments essential for blood clotting and hemostasis. They aggregate at damaged blood vessel sites, form a platelet plug, and release factors that activate the coagulation cascade.

Thrombocytosis (>400,000): Infection, inflammation, iron deficiency, essential thrombocythemia
Thrombocytopenia (<150,000): ITP, TTP, bone marrow disorders, chemotherapy, viral infections
Clinical Significance

Platelets below 50,000/μL risk bleeding with surgery; below 20,000/μL risk spontaneous bleeding; below 10,000/μL require transfusion.

MPV (Mean Platelet Volume)

CBC

Also known as: mpv blood test normal range

Normal: 7.5-11.5 fL

MPV measures average platelet size, reflecting bone marrow platelet production activity. Larger platelets are younger, more metabolically active, and have greater thrombotic potential.

High MPV: Increased platelet turnover, ITP, cardiovascular disease risk, diabetes
Low MPV: Bone marrow suppression, aplastic conditions, sepsis
Clinical Significance

High MPV with low platelet count suggests peripheral destruction (ITP) rather than marrow failure. Elevated MPV is associated with increased cardiovascular risk.

Reticulocyte Count

CBC

Also known as: normal reticulocyte count, Retic Count

Normal: 0.5-2.5% (25,000-125,000/μL)

Reticulocytes are immature red blood cells released from bone marrow. They reflect bone marrow's ability to respond to anemia and classify anemia as hypo-regenerative (low reticulocytes) or regenerative (high reticulocytes).

High Reticulocytes: Hemolytic anemia, acute blood loss, recovery from iron/B12/folate treatment
Low Reticulocytes: Aplastic anemia, bone marrow failure, untreated nutritional deficiency
Clinical Significance

Reticulocyte response after treating nutritional deficiency confirms diagnosis—expect rise within 3-5 days of iron/B12 supplementation.

Liver Function Biomarkers

15+ markers

ALT (Alanine Aminotransferase)

Liver

Also known as: SGPT, Alanine Transaminase, ALT SGPT

Normal: 7-56 U/L (men may be slightly higher)

ALT is an enzyme found predominantly in liver cells (hepatocytes), making it highly specific for liver damage. When liver cells are injured, ALT leaks into the bloodstream. ALT is more liver-specific than AST and is the primary marker for hepatocellular injury, particularly useful in diagnosing and monitoring viral hepatitis, fatty liver disease, and drug-induced liver injury.

Elevated ALT: Viral hepatitis (A, B, C), NAFLD/NASH, alcoholic liver disease, drug-induced hepatotoxicity, autoimmune hepatitis, ischemic hepatitis, Wilson disease
Very High ALT (>1000): Acute viral hepatitis, drug/toxin-induced hepatitis, ischemic hepatitis ("shock liver"), acute autoimmune hepatitis
Clinical Significance

Mild ALT elevation (1-3x normal) is common and often due to fatty liver or medications. Moderate elevation (3-10x) suggests significant liver disease requiring evaluation. Severe elevation (>10x or >1000 U/L) indicates acute hepatocellular injury—urgent workup needed. AST/ALT ratio >2 suggests alcoholic liver disease.

AST (Aspartate Aminotransferase)

Liver

Also known as: SGOT, Aspartate Transaminase, AST Blood Test Definition

Normal: 10-40 U/L

AST is an enzyme found in liver, heart, muscle, kidney, and brain tissues. Unlike ALT, elevated AST is less specific for liver disease and may indicate cardiac or skeletal muscle damage. AST exists in two forms: cytoplasmic (released with mild injury) and mitochondrial (released with severe cell damage). The AST/ALT ratio helps differentiate liver disease causes.

Elevated AST: Liver disease, myocardial infarction, muscle injury/rhabdomyolysis, hemolysis, strenuous exercise, medications
Low AST (SGOT Low): Vitamin B6 deficiency (AST requires B6 as cofactor), uremia, chronic dialysis—rarely clinically significant
Clinical Significance

AST/ALT ratio >2:1 strongly suggests alcoholic liver disease. Ratio <1 is typical for viral hepatitis and NAFLD. Isolated AST elevation with normal ALT should prompt evaluation for non-hepatic sources (cardiac, muscle). In cirrhosis, AST often exceeds ALT as liver synthetic function declines.

Alkaline Phosphatase (ALP)

Liver

Also known as: Alk Phos, AP

Normal: 44-147 U/L (higher in children and pregnancy)

ALP is found in liver (biliary epithelium), bone, intestine, kidney, and placenta. Elevated ALP indicates cholestatic (biliary) liver disease or bone disorders. ALP rises when bile flow is obstructed, making it a marker for biliary obstruction, primary biliary cholangitis, and infiltrative liver diseases. Bone ALP increases with increased bone turnover.

Hepatic Causes: Bile duct obstruction, primary biliary cholangitis, primary sclerosing cholangitis, drug-induced cholestasis, liver metastases, infiltrative diseases
Bone Causes: Paget disease, bone metastases, healing fractures, hyperparathyroidism, osteomalacia, growing children
Clinical Significance

Elevated ALP with elevated GGT confirms hepatic origin. Isolated ALP elevation may be bone-related—check GGT or ALP isoenzymes. Very high ALP (>3x normal) with normal transaminases suggests cholestasis or bone disease. In pregnancy, placental ALP elevates levels 2-3x in third trimester—this is normal.

GGT (Gamma-Glutamyl Transferase)

Liver

Also known as: Gamma GT, GGTP, Gamma G Transferase

Normal: 9-48 U/L (men often higher than women)

GGT is a sensitive but non-specific marker of liver and biliary disease, found in liver, kidneys, pancreas, and intestines. It's particularly useful for confirming hepatic origin of elevated ALP and detecting alcohol-related liver damage. GGT is induced by alcohol and certain medications, making it a marker of alcohol use even without liver disease.

Elevated GGT: Alcohol use (even moderate), biliary disease, fatty liver, hepatitis, medications (phenytoin, barbiturates), pancreatitis, diabetes, heart failure
Uses: Confirm hepatic ALP elevation, screen for alcohol abuse, monitor alcohol abstinence
Clinical Significance

GGT is highly sensitive but non-specific—many conditions and medications elevate it. Isolated GGT elevation often indicates alcohol use or enzyme induction rather than liver disease. However, elevated GGT independently predicts cardiovascular disease and mortality, possibly reflecting metabolic syndrome and oxidative stress.

Total Bilirubin

Liver

Also known as: TBIL, Serum Bilirubin

Normal: 0.1-1.2 mg/dL (1.7-20.5 μmol/L)

Bilirubin is the yellow breakdown product of heme from red blood cell destruction. The liver conjugates (makes water-soluble) bilirubin for excretion in bile. Total bilirubin includes unconjugated (indirect) and conjugated (direct) forms. Elevated bilirubin causes jaundice—yellowing of skin and eyes visible when levels exceed 2.5-3 mg/dL.

Unconjugated Hyperbilirubinemia: Hemolysis, Gilbert syndrome (benign), ineffective erythropoiesis, large hematoma resorption, neonatal jaundice
Conjugated Hyperbilirubinemia: Hepatocellular disease, bile duct obstruction, Dubin-Johnson syndrome, drug-induced cholestasis
Clinical Significance

Direct (conjugated) bilirubin >50% of total indicates hepatobiliary disease. Isolated unconjugated hyperbilirubinemia (1.5-4 mg/dL) with normal liver tests suggests Gilbert syndrome, a benign genetic condition affecting 5-10% of population. Bilirubin >20 mg/dL with elevated INR indicates severe liver failure.

Albumin

Liver

Also known as: Serum Albumin, ALB

Normal: 3.5-5.0 g/dL (35-50 g/L)

Albumin is the most abundant plasma protein, synthesized exclusively by the liver. It maintains oncotic pressure (preventing fluid leakage from blood vessels), transports hormones, fatty acids, drugs, and bilirubin, and serves as a marker of liver synthetic function and nutritional status. Albumin has a half-life of ~20 days, so levels change slowly.

Low Albumin: Chronic liver disease, nephrotic syndrome, malnutrition, protein-losing enteropathy, severe burns, chronic inflammation, sepsis
Clinical Effects: Edema, ascites, impaired drug binding, reduced wound healing, increased mortality risk
Clinical Significance

Albumin <3.0 g/dL indicates significant liver dysfunction or other pathology. In cirrhosis, low albumin indicates poor prognosis and is part of Child-Pugh scoring. Low albumin affects calcium interpretation (correct calcium for albumin) and drug dosing. Albumin <2.0 g/dL causes significant edema and ascites.

Total Protein

Liver

Also known as: TP, Serum Total Protein, Total Protein in Blood Test

Normal: 6.0-8.3 g/dL (60-83 g/L)

Total protein measures all proteins in serum, primarily albumin (60%) and globulins (40%). Albumin is made by the liver, while globulins include immunoglobulins (antibodies) made by plasma cells and other proteins. Total protein reflects nutritional status, liver function, kidney function, and immune system activity. The albumin/globulin ratio provides additional diagnostic information.

High Total Protein: Multiple myeloma, chronic infections, autoimmune diseases (high globulins), dehydration, HIV/AIDS
Low Total Protein: Liver disease, kidney disease (nephrotic syndrome), malnutrition, malabsorption, overhydration, protein-losing conditions
Clinical Significance

Albumin/Globulin ratio (A/G ratio) normally exceeds 1.0. Low A/G ratio (<1.0) may indicate liver disease, kidney disease, or elevated immunoglobulins. Very high total protein (>9 g/dL) with low albumin suggests monoclonal gammopathy requiring serum protein electrophoresis (SPEP) and evaluation for multiple myeloma.

Globulin

Liver

Also known as: Serum Globulin, Alpha 1 Globulin, Alpha 2 Globulin, Low/High Globulin Levels

Normal: 2.3-3.5 g/dL (calculated: Total Protein - Albumin)

Globulins are a diverse group of proteins including alpha-1 globulins (alpha-1 antitrypsin, alpha-fetoprotein), alpha-2 globulins (haptoglobin, ceruloplasmin), beta globulins (transferrin, complement), and gamma globulins (immunoglobulins/antibodies). Serum protein electrophoresis (SPEP) separates these fractions for detailed analysis.

High Globulin: Chronic infections, autoimmune diseases, chronic liver disease, multiple myeloma, Waldenström macroglobulinemia, sarcoidosis
Low Globulin: Immunodeficiency states, nephrotic syndrome, acute illness, malnutrition, agammaglobulinemia
Clinical Significance

Alpha-1 globulin elevation occurs in acute inflammation; decreased levels suggest alpha-1 antitrypsin deficiency causing emphysema and liver disease. Alpha-2 globulin rises in nephrotic syndrome and acute inflammation. High gamma globulins (hypergammaglobulinemia) may be polyclonal (chronic infection, autoimmune) or monoclonal (myeloma—requires SPEP).

Kidney Function Biomarkers

10+ markers

Cystatin C

Kidney

Also known as: CysC

Normal: 0.53-0.95 mg/L

Cystatin C is a small protein produced by all nucleated cells at a constant rate, freely filtered by glomeruli, and completely reabsorbed and catabolized by tubules. Unlike creatinine, cystatin C is independent of muscle mass, age, sex, and diet, making it more accurate for GFR estimation in elderly, malnourished, or muscular individuals.

Advantages: More accurate in extremes of muscle mass, elderly, children; earlier detection of kidney dysfunction; better predictor of cardiovascular events
Limitations: Affected by thyroid dysfunction, corticosteroids, inflammation; more expensive than creatinine
Clinical Significance

Cystatin C-based eGFR (eGFRcys) or combined creatinine-cystatin C equations (eGFRcr-cys) may be more accurate than creatinine alone. Consider cystatin C when creatinine-based eGFR may be inaccurate: extremes of body size, amputees, muscle-wasting conditions, vegetarians, and when confirming CKD diagnosis near stage thresholds.

Uric Acid

Kidney

Also known as: Serum Urate

Normal: 3.5-7.2 mg/dL (men) | 2.6-6.0 mg/dL (women)

Uric acid is the end product of purine metabolism in humans (we lack uricase enzyme). Purines come from dietary sources (red meat, seafood, beer) and cellular breakdown. Two-thirds of uric acid is excreted by kidneys; one-third by the gut. When uric acid exceeds its solubility (~6.8 mg/dL), monosodium urate crystals can precipitate in joints (gout) or kidneys (stones).

High Uric Acid: Gout, kidney disease, diuretics, high-purine diet, tumor lysis syndrome, myeloproliferative disorders, metabolic syndrome, lead poisoning
Low Uric Acid: SIADH, Fanconi syndrome, Wilson disease, xanthine oxidase deficiency, uricosuric drugs
Clinical Significance

Uric acid >9 mg/dL significantly increases gout risk. Target <6 mg/dL for gout prevention and <5 mg/dL with tophi. Asymptomatic hyperuricemia doesn't require treatment but indicates cardiovascular risk. Tumor lysis syndrome causes acute hyperuricemia (often >15 mg/dL) with acute kidney injury—prevent with allopurinol/rasburicase.

Urobilinogen

Kidney

Also known as: UA Urobilinogen, Urobilinogen in Urine Test

Normal in urine: 0.2-1.0 mg/dL (Ehrlich Units)

Urobilinogen is produced when intestinal bacteria reduce bilirubin. Most is excreted in feces (as stercobilin, giving stool its brown color), but some is reabsorbed and excreted in urine. Urobilinogen in urine reflects bilirubin metabolism and enterohepatic circulation. High levels indicate increased bilirubin production or liver dysfunction; absent levels suggest bile duct obstruction.

High Urobilinogen: Hemolytic anemia, liver disease (hepatitis, cirrhosis), increased bilirubin production, heart failure with hepatic congestion
Absent Urobilinogen: Complete bile duct obstruction, broad-spectrum antibiotics (kill gut bacteria), severe cholestasis
Clinical Significance

Urobilinogen is part of routine urinalysis. Elevated urobilinogen with elevated serum bilirubin suggests hemolysis or liver dysfunction. Absent urobilinogen with elevated direct bilirubin indicates obstructive jaundice. The combination of urobilinogen and urine bilirubin helps differentiate jaundice causes: hemolytic (high urobilinogen, no urine bilirubin), hepatocellular (high both), obstructive (no urobilinogen, high urine bilirubin).

Thyroid Function Biomarkers

10+ markers

TSH (Thyroid Stimulating Hormone)

Thyroid

Also known as: Thyrotropin

Normal: 0.4-4.0 mIU/L (some labs use 0.5-5.0)

TSH is produced by the pituitary gland and regulates thyroid hormone production through negative feedback. It's the most sensitive screening test for thyroid dysfunction. When thyroid hormones drop, TSH rises (hypothyroidism); when thyroid hormones are excessive, TSH is suppressed (hyperthyroidism). TSH changes exponentially with small changes in free T4.

High TSH: Primary hypothyroidism (Hashimoto's, post-thyroidectomy, radioiodine, iodine deficiency), recovery from non-thyroidal illness, TSH-secreting pituitary adenoma (rare)
Low TSH: Hyperthyroidism (Graves' disease, toxic nodule), excessive thyroid hormone replacement, early pregnancy, central hypothyroidism (rare)
Clinical Significance

TSH is first-line screening—if abnormal, check free T4 (and sometimes free T3). Subclinical hypothyroidism (TSH 5-10, normal T4) may warrant treatment if symptomatic, TPO antibodies positive, or TSH >10. Subclinical hyperthyroidism (TSH 0.1-0.4, normal T4) risks atrial fibrillation and osteoporosis. TSH <0.1 requires evaluation and usually treatment.

Free T4 (Free Thyroxine)

Thyroid

Also known as: FT4, Free Thyroxine

Normal: 0.8-1.8 ng/dL (10-23 pmol/L)

T4 (thyroxine) is the main hormone produced by the thyroid gland. About 99.97% is protein-bound; only 0.03% is "free" and biologically active. Free T4 is converted to T3 (the active hormone) in peripheral tissues. Measuring free T4 avoids interference from protein binding changes that affect total T4 (pregnancy, estrogen, liver disease).

High Free T4: Hyperthyroidism (Graves', toxic nodule), thyroiditis (transient), excessive levothyroxine, amiodarone, severe illness (non-thyroidal illness syndrome)
Low Free T4: Primary hypothyroidism, secondary/central hypothyroidism, severe illness, inadequate thyroid hormone replacement
Clinical Significance

Free T4 confirms thyroid status when TSH is abnormal. High TSH + low FT4 = overt hypothyroidism requiring treatment. Low TSH + high FT4 = overt hyperthyroidism. Normal FT4 with abnormal TSH = subclinical disease. In central hypothyroidism, both TSH and FT4 are low—monitor FT4 rather than TSH for treatment adequacy.

Free T3 (Free Triiodothyronine)

Thyroid

Also known as: FT3

Normal: 2.3-4.2 pg/mL (3.5-6.5 pmol/L)

T3 is the biologically active thyroid hormone, 3-5 times more potent than T4. About 80% of T3 is produced by peripheral conversion of T4 by deiodinase enzymes; only 20% comes directly from the thyroid. T3 is essential for metabolism, heart rate, body temperature, and cognitive function. Free T3 represents the unbound, active fraction.

High Free T3: Hyperthyroidism (especially T3 toxicosis), early Graves' disease, T3-secreting nodule, excessive T3 supplementation
Low Free T3: Non-thyroidal illness ("sick euthyroid"), severe hypothyroidism, calorie restriction, medications (propranolol, amiodarone, steroids)
Clinical Significance

Free T3 is most useful when hyperthyroidism is suspected but FT4 is normal (T3 toxicosis, early Graves'). In hypothyroidism, FT3 often remains normal longer than FT4 and isn't needed routinely. Low T3 syndrome occurs in severe illness without true thyroid dysfunction—treating with T3 hasn't shown benefit. Elevated FT3/FT4 ratio suggests Graves' disease.

Anti-TPO Antibodies

Thyroid

Also known as: Thyroid Peroxidase Antibodies, TPOAb, Anti-TPO

Normal: <35 IU/mL (reference ranges vary by assay)

Anti-TPO antibodies target thyroid peroxidase, the enzyme essential for thyroid hormone synthesis. These autoantibodies are the most sensitive marker of autoimmune thyroid disease. They're found in over 90% of Hashimoto's thyroiditis and 70% of Graves' disease patients. Presence indicates autoimmune thyroid inflammation even when thyroid function is currently normal.

Positive Anti-TPO: Hashimoto's thyroiditis, Graves' disease, postpartum thyroiditis, other autoimmune diseases (lupus, RA, type 1 diabetes), 10-15% of healthy population
Clinical Use: Confirm autoimmune etiology, predict progression to overt hypothyroidism, assess postpartum thyroiditis risk
Clinical Significance

Positive anti-TPO with subclinical hypothyroidism predicts 4-5% annual progression to overt hypothyroidism—favors earlier treatment. Higher antibody levels correlate with greater risk. Positive anti-TPO in euthyroid patients indicates need for periodic TSH monitoring. In pregnancy, positive anti-TPO increases miscarriage and postpartum thyroiditis risk.

Coagulation Biomarkers

10+ markers

PT/INR (Prothrombin Time)

Coagulation

Also known as: Pro Time, INR

Normal PT: 11-13.5 seconds | Normal INR: 0.8-1.1 | Therapeutic INR: 2.0-3.0

PT measures the extrinsic and common coagulation pathway function (factors I, II, V, VII, X). INR (International Normalized Ratio) standardizes PT results across laboratories using different reagents. PT/INR monitors warfarin therapy and assesses liver synthetic function. Vitamin K-dependent factors (II, VII, IX, X) are affected by warfarin and liver disease.

Prolonged PT/INR: Warfarin therapy, vitamin K deficiency, liver disease, DIC, factor deficiencies, direct oral anticoagulants (DOACs)
Warfarin Targets: INR 2.0-3.0 for most indications; INR 2.5-3.5 for mechanical heart valves
Clinical Significance

INR >4.0 increases major bleeding risk; >10 may require vitamin K and/or fresh frozen plasma. In liver disease, PT/INR reflects synthetic function but doesn't predict bleeding risk well (balanced defects in pro- and anticoagulant factors). PT corrects with vitamin K in deficiency but not in liver failure.

aPTT (Activated Partial Thromboplastin Time)

Coagulation

Also known as: PTT, aPTT Normal Range, High aPTT, aPTT Laboratory Test

Normal: 25-35 seconds (varies by laboratory)

aPTT measures the intrinsic and common coagulation pathway function (factors I, II, V, VIII, IX, X, XI, XII). It's used to monitor unfractionated heparin therapy and screen for bleeding disorders like hemophilia A (factor VIII deficiency) and hemophilia B (factor IX deficiency). aPTT is also prolonged by lupus anticoagulant (paradoxically increases clotting risk).

Prolonged aPTT: Heparin therapy, hemophilia A/B, von Willebrand disease, factor XI/XII deficiency, lupus anticoagulant, DIC, liver disease
Mixing Study: Corrects = factor deficiency; Doesn't correct = inhibitor (lupus anticoagulant, factor-specific antibody)
Clinical Significance

For heparin monitoring, target aPTT is typically 1.5-2.5x baseline (60-80 seconds). Isolated prolonged aPTT without bleeding history may indicate lupus anticoagulant or factor XII deficiency (neither causes bleeding). Prolonged aPTT with bleeding suggests hemophilia—order factor VIII and IX levels. Always check if patient is on anticoagulants before interpreting.

D-Dimer

Coagulation

Also known as: Elevated D-Dimer Meaning, Fibrin Degradation Product

Normal: <500 ng/mL (FEU) or <250 ng/mL (DDU)

D-dimer is a fibrin degradation product formed when plasmin breaks down cross-linked fibrin in blood clots. Elevated D-dimer indicates recent or ongoing clot formation and breakdown. It's a highly sensitive but non-specific test for venous thromboembolism (VTE)—a negative D-dimer effectively rules out DVT and PE in low-risk patients.

Elevated D-Dimer: DVT, pulmonary embolism, DIC, surgery, trauma, pregnancy, cancer, infection, inflammation, liver disease, increasing age
Age-Adjusted Cutoff: Age × 10 ng/mL for patients >50 years (e.g., 700 ng/mL for 70-year-old)
Clinical Significance

D-dimer's value is in its negative predictive value—normal D-dimer with low/moderate clinical probability excludes VTE. Positive D-dimer doesn't confirm clot—imaging required. In DIC, D-dimer is markedly elevated with low platelets and prolonged PT/aPTT. Use age-adjusted cutoffs in elderly to improve specificity without losing sensitivity.

Fibrinogen

Coagulation

Also known as: Factor I, Clotting Factor I

Normal: 200-400 mg/dL

Fibrinogen is a glycoprotein synthesized by the liver and converted to fibrin by thrombin during clot formation. It's both a coagulation factor (essential for clot stability) and an acute phase reactant (rises with inflammation). Fibrinogen levels affect both bleeding risk (when low) and thrombotic risk (when elevated, as it promotes platelet aggregation and increases blood viscosity).

High Fibrinogen: Inflammation, infection, cancer, pregnancy, smoking, obesity, diabetes—increases cardiovascular risk
Low Fibrinogen: DIC (consumed), severe liver disease, fibrinolytic therapy, massive transfusion, congenital deficiency
Clinical Significance

Fibrinogen <100 mg/dL increases bleeding risk significantly; <50 mg/dL during active bleeding requires cryoprecipitate or fibrinogen concentrate. In DIC, declining fibrinogen with rising D-dimer confirms consumptive coagulopathy. Elevated fibrinogen is an independent cardiovascular risk factor but no treatment targets it specifically.

Cardiac Biomarkers

10+ markers

Troponin I/T (High-Sensitivity)

Cardiac

Also known as: hs-TnI, hs-TnT, Cardiac Troponin

Normal: <14 ng/L (hs-TnT) | <26 ng/L (hs-TnI) - varies by assay

Cardiac troponins are structural proteins in heart muscle released when cardiomyocytes are damaged. High-sensitivity troponin assays detect very low levels, enabling earlier MI detection but also detecting non-ischemic cardiac injury. Troponin is the gold standard for diagnosing myocardial infarction, with a rise and/or fall pattern with at least one value above the 99th percentile.

Elevated Troponin: Acute MI, myocarditis, heart failure, pulmonary embolism, sepsis, renal failure, cardiac contusion, ablation, cardioversion
MI Diagnosis: Rise and/or fall pattern with ≥1 value above 99th percentile + clinical evidence of ischemia
Clinical Significance

Troponin rise above 99th percentile indicates myocardial injury—context determines if it's MI. Serial troponins (0h, 1-3h) showing rise/fall pattern suggest acute injury. Chronic stable elevations (common in CKD, heart failure) indicate chronic injury, not acute MI. Very high troponin (>10x URL) strongly suggests acute MI.

BNP / NT-proBNP

Cardiac

Also known as: Brain Natriuretic Peptide, What is a Dangerous BNP Level

BNP: <100 pg/mL rules out HF | NT-proBNP: <300 pg/mL rules out acute HF

BNP and NT-proBNP are released from ventricular myocytes in response to wall stretch and volume overload. They're the primary biomarkers for diagnosing and prognosticating heart failure. BNP has a shorter half-life (20 min) than NT-proBNP (120 min), so NT-proBNP levels are higher. Both correlate with heart failure severity and predict adverse outcomes.

Elevated Levels: Heart failure, acute coronary syndrome, pulmonary embolism, atrial fibrillation, renal failure, pulmonary hypertension, sepsis
Age-Adjusted NT-proBNP: <450 pg/mL (age <50), <900 pg/mL (50-75), <1800 pg/mL (age >75) to rule out acute HF
Clinical Significance

BNP/NT-proBNP help distinguish cardiac from pulmonary causes of dyspnea. Low levels (<100/300) effectively rule out heart failure. Very high levels (BNP >500, NT-proBNP >900-1800) indicate significant HF. Levels guide prognosis and response to therapy—a 30% reduction indicates treatment response. Obesity falsely lowers levels; renal failure falsely elevates them.

CK-MB (Creatine Kinase-MB)

Cardiac

Also known as: Creatine Kinase CPK Normal Range

Normal: 0-6.3 ng/mL (or <5% of total CK)

CK-MB is the cardiac-specific isoenzyme of creatine kinase, formerly the gold standard for MI diagnosis before troponin. It rises 4-6 hours after MI, peaks at 12-24 hours, and normalizes in 2-3 days. Its faster clearance makes CK-MB useful for detecting reinfarction when troponin remains elevated from the initial event.

Elevated CK-MB: Myocardial infarction, myocarditis, cardiac surgery, cardioversion, some muscular dystrophies
CK-MB Index: (CK-MB / Total CK) × 100; ratio >2.5-3% suggests cardiac source
Clinical Significance

Troponin has largely replaced CK-MB for MI diagnosis. CK-MB remains useful for: (1) detecting reinfarction when troponin still elevated, (2) timing of MI (CK-MB elevation helps estimate when MI occurred), (3) settings where troponin unavailable. CK-MB from skeletal muscle can cause false positives—check CK-MB index.

LDH (Lactate Dehydrogenase)

Cardiac

Also known as: LDH Blood Test for What, LDH Normal Range, LDH Values Normal

Normal: 140-280 U/L (varies by laboratory)

LDH is a cytoplasmic enzyme found in virtually all tissues including heart, liver, muscle, kidney, and red blood cells. When cells are damaged, LDH leaks into blood. Five isoenzymes exist: LDH-1 and LDH-2 predominate in heart and RBCs; LDH-4 and LDH-5 in liver and skeletal muscle. LDH is non-specific but useful for monitoring tissue damage, hemolysis, and certain cancers.

Elevated LDH: Hemolysis, MI (late marker), liver disease, muscle injury, lymphoma/leukemia, pulmonary embolism, tumor lysis, megaloblastic anemia
Diagnostic Uses: Hemolysis detection, tumor marker (lymphoma, testicular cancer), TTP monitoring, pernicious anemia
Clinical Significance

LDH is too nonspecific for MI diagnosis (troponin preferred). High LDH with low haptoglobin and elevated indirect bilirubin confirms hemolysis. Very high LDH (>1000 U/L) suggests lymphoma, leukemia, hemolysis, or widespread tissue destruction. LDH is a prognostic marker in many cancers—higher levels indicate worse prognosis.

Vitamins & Minerals Biomarkers

15+ markers

Serum Iron

Vitamins

Also known as: Iron Saturation, What is Iron Saturation

Normal: 60-170 μg/dL (men) | 50-150 μg/dL (women)

Serum iron measures the amount of iron bound to transferrin in blood. Iron is essential for hemoglobin synthesis, oxygen transport, and enzymatic functions. Serum iron alone has limited diagnostic value due to diurnal variation and rapid changes with diet; it must be interpreted with TIBC and ferritin for complete iron status assessment.

Low Iron: Iron deficiency anemia, chronic blood loss, malabsorption, inadequate dietary intake, chronic inflammatory conditions
High Iron: Hemochromatosis, iron overload from transfusions, hemolytic anemia, liver disease, acute hepatitis
Clinical Significance

Iron saturation (iron/TIBC × 100) is more informative: <16% suggests iron deficiency; >45% suggests iron overload. In iron deficiency: low iron, high TIBC, low ferritin, low saturation. In anemia of chronic disease: low iron, low TIBC, normal/high ferritin. Fasting morning samples preferred due to diurnal variation.

Ferritin

Vitamins

Also known as: Serum Ferritin, Iron Stores

Normal: 12-300 ng/mL (men) | 12-150 ng/mL (women)

Ferritin is the primary iron storage protein, with small amounts released into blood reflecting total body iron stores. It's the most sensitive marker for iron deficiency—low ferritin is diagnostic. However, ferritin is also an acute phase reactant, rising with inflammation, infection, liver disease, and malignancy, which can mask underlying iron deficiency.

Low Ferritin (<30): Iron deficiency (most specific marker), chronic blood loss, malabsorption, dietary deficiency
High Ferritin: Iron overload (hemochromatosis), inflammation, infection, liver disease, malignancy, hemolytic anemia, metabolic syndrome
Clinical Significance

Ferritin <30 ng/mL confirms iron deficiency with 99% specificity. In inflammation (elevated CRP), ferritin <100 ng/mL suggests concurrent iron deficiency. Very high ferritin (>1000 ng/mL) may indicate hemochromatosis, Still's disease, hemophagocytic syndrome, or liver disease. Ferritin goal in iron replacement: 100-200 ng/mL.

TIBC (Total Iron-Binding Capacity)

Vitamins

Also known as: TIBC Blood Test High, High Iron Binding Capacity, High Unbound Iron Binding Capacity

Normal: 250-450 μg/dL

TIBC measures the maximum amount of iron that transferrin can bind, indirectly reflecting transferrin levels. When iron stores are depleted, the liver produces more transferrin, increasing TIBC. Conversely, in iron overload or inflammation, transferrin production decreases, lowering TIBC. TIBC and transferrin saturation are essential for complete iron status assessment.

High TIBC (>450): Iron deficiency (body compensates by producing more transferrin), pregnancy, oral contraceptive use
Low TIBC (<250): Anemia of chronic disease, iron overload, malnutrition, liver disease, nephrotic syndrome
Clinical Significance

The pattern of iron studies differentiates anemias: Iron deficiency = low iron, high TIBC, low ferritin, low saturation. Chronic disease anemia = low iron, low/normal TIBC, normal/high ferritin. Iron overload = high iron, low TIBC, high ferritin, high saturation (>45%). Calculate transferrin saturation: (serum iron ÷ TIBC) × 100.

Vitamin B12 (Cobalamin)

Vitamins

Also known as: Cyanocobalamin

Normal: 200-900 pg/mL (148-664 pmol/L)

Vitamin B12 is essential for DNA synthesis, red blood cell formation, and neurological function. It's absorbed in the terminal ileum bound to intrinsic factor from stomach parietal cells. B12 deficiency causes megaloblastic anemia and neurological damage (subacute combined degeneration) that can be irreversible if untreated. Body stores last 3-5 years.

Low B12: Pernicious anemia (anti-IF antibodies), gastrectomy/ileal resection, vegan diet, metformin use, atrophic gastritis, H. pylori, tapeworm
Symptoms: Fatigue, macrocytic anemia, glossitis, peripheral neuropathy, cognitive decline, depression, ataxia
Clinical Significance

B12 <200 pg/mL with symptoms confirms deficiency. Gray zone (200-400 pg/mL) needs methylmalonic acid (MMA) confirmation—elevated MMA indicates functional B12 deficiency. Neurological symptoms can occur without anemia. Treat pernicious anemia with injections (oral won't absorb); dietary deficiency responds to oral supplementation. Don't give folate alone—masks B12 deficiency while neurological damage progresses.

Folate (Folic Acid)

Vitamins

Also known as: Vitamin B9, Raised Folate Levels

Normal: 2-20 ng/mL (serum) | >140 ng/mL (RBC folate)

Folate is a B vitamin essential for DNA synthesis and cell division. It's found in leafy greens, legumes, and fortified foods. Folate deficiency causes megaloblastic anemia identical to B12 deficiency but without neurological complications. Adequate folate before and during early pregnancy prevents neural tube defects. RBC folate reflects longer-term stores than serum folate.

Low Folate: Inadequate intake, alcoholism, malabsorption (celiac, IBD), pregnancy, medications (methotrexate, phenytoin, trimethoprim)
Raised Folate: Excessive supplementation, vegetarian diet, B12 deficiency (folate trapped in cells), bacterial overgrowth
Clinical Significance

Always check B12 with folate—treating folate deficiency can mask B12 deficiency while neurological damage continues. Serum folate reflects recent intake; RBC folate reflects status over 2-3 months. Folate supplementation (400-800 mcg daily) recommended for all women of childbearing age. Methotrexate patients need folate supplementation to reduce side effects.

Vitamin D (25-Hydroxyvitamin D)

Vitamins

Also known as: 25-OH Vitamin D, Calcidiol

Optimal: 30-100 ng/mL | Insufficient: 20-29 | Deficient: <20 ng/mL

Vitamin D is a fat-soluble vitamin essential for calcium absorption, bone health, immune function, and cell growth regulation. It's synthesized in skin from sun exposure and obtained from diet (fatty fish, fortified foods). 25-OH vitamin D is the best measure of vitamin D status, reflecting both dietary intake and skin synthesis. Deficiency is extremely common, especially at higher latitudes.

Deficiency Risk: Limited sun exposure, dark skin, obesity, malabsorption, elderly, kidney/liver disease, northern latitudes, institutionalized individuals
Symptoms: Bone pain, muscle weakness, fatigue, depression, frequent infections, osteomalacia/rickets
Clinical Significance

Vitamin D <20 ng/mL requires treatment; <10 ng/mL is severe deficiency. Treatment: 50,000 IU weekly × 8-12 weeks for deficiency, then maintenance 1,000-2,000 IU daily. Check PTH with vitamin D—secondary hyperparathyroidism suggests functional deficiency. Toxicity rare but possible with levels >150 ng/mL (hypercalcemia, kidney stones).

Hormone Biomarkers

20+ markers

Testosterone (Total)

Hormones
Normal: 280-1100 ng/dL (men) | 15-70 ng/dL (women)

Testosterone is the primary male sex hormone produced mainly by testes in men and ovaries/adrenal glands in women. It regulates libido, muscle mass, bone density, red blood cell production, and mood. Total testosterone includes both bound and free forms. Free testosterone (1-2% of total) is the biologically active fraction.

Clinical Significance

Low testosterone in men causes fatigue, decreased libido, erectile dysfunction, and muscle loss. High testosterone in women suggests PCOS or adrenal tumors. Morning samples preferred due to diurnal variation. Check SHBG and free testosterone if total testosterone is borderline.

Estradiol (E2)

Hormones
Varies by menstrual phase | Postmenopausal: <30 pg/mL

Estradiol is the most potent estrogen, produced primarily by ovaries in premenopausal women. It regulates the menstrual cycle, bone density, cardiovascular health, and skin integrity. Levels fluctuate dramatically during the menstrual cycle, peaking before ovulation.

Clinical Significance

Low estradiol indicates menopause, premature ovarian failure, or hypogonadism. High levels may suggest ovarian tumors, liver disease, or obesity (aromatization). Essential for fertility workup and monitoring hormone replacement therapy.

Cortisol

Hormones
AM (8am): 6-23 μg/dL | PM (4pm): 3-15 μg/dL

Cortisol is the primary stress hormone produced by the adrenal cortex. It regulates metabolism, immune response, blood pressure, and glucose levels. Cortisol follows a diurnal pattern, highest in the morning and lowest at midnight. Chronic elevation causes Cushing syndrome; deficiency causes Addison disease.

Clinical Significance

Morning cortisol <3 μg/dL suggests adrenal insufficiency; >18 μg/dL makes insufficiency unlikely. 24-hour urine cortisol or late-night salivary cortisol are better for Cushing syndrome screening. Stress can elevate levels 2-3x.

DHEA-S (Why Take DHEA at Night)

Hormones
Age-specific: 65-380 μg/dL (women) | 80-560 μg/dL (men)

DHEA-S (dehydroepiandrosterone sulfate) is an adrenal androgen that serves as precursor to both testosterone and estrogen. It's the most abundant steroid hormone in circulation. DHEA-S levels decline progressively with age, leading some to supplement for anti-aging effects (though evidence is limited).

Clinical Significance

Elevated DHEA-S in women suggests adrenal source of androgens (vs ovarian). Very high levels may indicate adrenal tumor. Low levels occur with adrenal insufficiency. Some people take DHEA supplements at night to mimic natural cortisol rhythm, though timing evidence is weak.

FSH (Follicle Stimulating Hormone)

Hormones
Follicular: 3-10 mIU/mL | Postmenopausal: 25-135 mIU/mL

FSH is a pituitary hormone that stimulates ovarian follicle development in women and sperm production in men. FSH levels are used to evaluate fertility, menopause, and gonadal function. In menopause, ovarian feedback is lost and FSH rises dramatically.

Clinical Significance

FSH >25-40 mIU/mL in women under 40 suggests premature ovarian failure. Day 3 FSH >10 mIU/mL indicates diminished ovarian reserve. In men, elevated FSH with low testosterone suggests primary hypogonadism. Low FSH suggests pituitary problem.

LH (Luteinizing Hormone)

Hormones
Follicular: 2-15 mIU/mL | Midcycle peak: 30-150 mIU/mL

LH is a pituitary hormone that triggers ovulation in women and stimulates testosterone production in men. The LH surge at mid-cycle triggers egg release. LH/FSH ratio is important in diagnosing PCOS, where LH is often elevated relative to FSH.

Clinical Significance

LH/FSH ratio >2-3 suggests PCOS. Elevated LH with low testosterone in men indicates primary hypogonadism. Low LH suggests pituitary disease. LH is used in ovulation predictor kits—surge indicates ovulation within 24-48 hours.

Prolactin

Hormones
Normal: <20 ng/mL (women) | <15 ng/mL (men)

Prolactin is produced by the pituitary gland and primarily stimulates breast milk production. It also affects menstrual cycles and fertility. Stress, sleep, and meals can transiently elevate prolactin. Persistently elevated levels suggest prolactinoma or medication effect.

Clinical Significance

Prolactin >200 ng/mL strongly suggests prolactinoma; MRI indicated. Levels 25-200 may be drug-induced (antipsychotics, metoclopramide) or from pituitary stalk effect. High prolactin causes amenorrhea, galactorrhea, and infertility. Treat with dopamine agonists (cabergoline).

Fasting Insulin

Hormones
Optimal: 2-10 μIU/mL | Insulin resistance: >15-20 μIU/mL

Insulin is produced by pancreatic beta cells to regulate glucose uptake into cells. Fasting insulin levels help assess insulin resistance, a precursor to type 2 diabetes. High fasting insulin with normal glucose indicates the body is working harder to maintain normal blood sugar.

Clinical Significance

HOMA-IR (fasting insulin × fasting glucose ÷ 405) >2.5-3 indicates insulin resistance. High fasting insulin predicts diabetes years before glucose rises. Low insulin with high glucose suggests type 1 diabetes or advanced type 2. Insulin levels also help diagnose insulinoma.

PTH (Parathyroid Hormone)

Hormones
Normal: 10-55 pg/mL (intact PTH)

PTH is secreted by parathyroid glands in response to low calcium. It raises blood calcium by increasing bone resorption, kidney calcium reabsorption, and vitamin D activation. PTH must be interpreted with calcium—the combination determines diagnosis.

Clinical Significance

High PTH + high calcium = primary hyperparathyroidism (usually parathyroid adenoma). High PTH + low/normal calcium = secondary hyperparathyroidism (vitamin D deficiency, CKD). Low PTH + low calcium = hypoparathyroidism. Low PTH + high calcium = malignancy (PTHrP-mediated).

IGF-1 (Insulin-like Growth Factor 1)

Hormones
Age-specific: 100-400 ng/mL (adults, varies by age)

IGF-1 is produced mainly by the liver in response to growth hormone. It mediates most of GH's growth-promoting effects. Unlike GH which fluctuates throughout the day, IGF-1 is stable and better reflects overall GH status. IGF-1 is used to diagnose GH deficiency and acromegaly.

Clinical Significance

Low IGF-1 suggests GH deficiency; requires GH stimulation testing for confirmation. Elevated IGF-1 suggests acromegaly (GH excess from pituitary adenoma). Monitor IGF-1 to assess treatment response. Malnutrition, liver disease, and hypothyroidism lower IGF-1.

Autoimmune & Inflammatory Markers

15+ markers

ANA (Antinuclear Antibodies)

Autoimmune

Also known as: ANA Titer 1:320

Negative: <1:40 | Positive: ≥1:80 | High: ≥1:320

ANA are antibodies targeting components of cell nuclei. They're screening tests for systemic autoimmune diseases, particularly lupus (SLE). ANA is reported as titer (1:40, 1:80, 1:320, etc.) and pattern (homogeneous, speckled, nucleolar, centromere). Higher titers are more clinically significant.

Clinical Significance

Positive ANA occurs in 95% of SLE, but also in 5-15% of healthy individuals (especially elderly, women). ANA titer 1:320 or higher with clinical symptoms warrants further workup (dsDNA, anti-Smith, complement). Pattern helps predict disease: homogeneous suggests SLE, centromere suggests limited scleroderma.

Rheumatoid Factor (RF)

Autoimmune
Normal: <14 IU/mL

Rheumatoid factor is an autoantibody (usually IgM) directed against the Fc portion of IgG. While associated with rheumatoid arthritis, RF is not specific—it occurs in other autoimmune diseases, chronic infections, and even healthy elderly individuals. Anti-CCP is more specific for RA.

Clinical Significance

RF positive in 70-80% of RA patients but also in Sjögren's, SLE, hepatitis C, and healthy elderly. High RF titers (>3x normal) correlate with more severe RA and extra-articular manifestations. RF-positive RA tends to be more aggressive. Combine with anti-CCP for better RA diagnosis.

Anti-CCP (Anti-Cyclic Citrullinated Peptide)

Autoimmune
Negative: <20 U/mL

Anti-CCP antibodies target citrullinated proteins and are highly specific (95-98%) for rheumatoid arthritis. They can appear years before clinical RA develops and predict more aggressive, erosive disease. Anti-CCP is now part of RA classification criteria along with RF.

Clinical Significance

Anti-CCP positive with joint symptoms strongly suggests RA even if RF negative. Double positive (RF+ and anti-CCP+) predicts severe erosive disease. Anti-CCP can be positive 5-10 years before RA symptoms appear, allowing early treatment. Useful for differentiating RA from other arthritides.

CRP (C-Reactive Protein)

Autoimmune

Also known as: hs-CRP, Elevated CRP ICD-10

Normal: <3 mg/L | hs-CRP cardiac risk: <1 low, 1-3 moderate, >3 high

CRP is an acute phase protein produced by the liver in response to inflammation. It rises rapidly (within 6 hours) and dramatically (100-1000x) with infection, tissue injury, or inflammation. High-sensitivity CRP (hs-CRP) detects lower levels for cardiovascular risk assessment.

Clinical Significance

CRP >10 mg/L suggests significant inflammation or infection. Very high CRP (>100-200 mg/L) suggests bacterial infection. CRP falls rapidly with treatment—useful for monitoring. hs-CRP >3 mg/L indicates increased cardiovascular risk. CRP >10 invalidates hs-CRP for cardiac risk (acute process present).

ESR (Erythrocyte Sedimentation Rate)

Autoimmune
Normal: 0-20 mm/hr (men) | 0-30 mm/hr (women) | Increases with age

ESR measures how fast red blood cells settle in a tube over one hour. Inflammation increases fibrinogen and immunoglobulins, which cause RBCs to stack (rouleaux) and settle faster. ESR is nonspecific but useful for monitoring chronic inflammatory conditions and diagnosing temporal arteritis/polymyalgia rheumatica.

Clinical Significance

ESR rises slowly (days) and falls slowly compared to CRP. Very high ESR (>100 mm/hr) suggests temporal arteritis, multiple myeloma, infection, or malignancy. ESR >50 in someone with new headache warrants temporal arteritis workup. Age-adjusted upper limit: age/2 (men) or (age+10)/2 (women).

Complement C3

Autoimmune

Also known as: C3 Blood Test, C3 Complement Blood Test

Normal: 90-180 mg/dL

C3 is the central component of the complement system, an immune defense cascade that helps destroy pathogens. Low C3 occurs when complement is consumed (active autoimmune disease) or not produced (liver disease, genetic deficiency). C3 is both an acute phase reactant and consumed in active disease.

Clinical Significance

Low C3 with low C4 suggests classical pathway activation (SLE, cryoglobulinemia). Low C3 with normal C4 suggests alternative pathway activation (membranoproliferative GN). In SLE, falling C3/C4 with rising anti-dsDNA predicts flare. Persistently low complement suggests active disease requiring treatment.

Complement C4

Autoimmune

Also known as: C4 Laboratory Test

Normal: 10-40 mg/dL

C4 is part of the classical complement pathway, activated by antigen-antibody complexes. C4 is consumed early in immune complex diseases. Genetic C4 deficiency is common and predisposes to autoimmune disease. C4 testing helps diagnose and monitor lupus activity and hereditary angioedema.

Clinical Significance

Very low or undetectable C4 with normal C3 suggests hereditary angioedema (check C1-esterase inhibitor). Low C4 often the first complement abnormality in lupus flare. Persistently low C4 despite treatment may indicate genetic deficiency. C4 gene copy number varies—some people have constitutively low levels.

Haptoglobin

Autoimmune

Also known as: Elevated Haptoglobin

Normal: 30-200 mg/dL

Haptoglobin binds free hemoglobin released from lysed red blood cells, preventing kidney damage and conserving iron. Low haptoglobin is the most sensitive marker of intravascular hemolysis. The haptoglobin-hemoglobin complex is rapidly cleared by the liver, depleting haptoglobin during hemolysis.

Clinical Significance

Haptoglobin <25 mg/dL with elevated LDH and indirect bilirubin confirms hemolysis. Undetectable haptoglobin is nearly diagnostic of intravascular hemolysis. Haptoglobin is also an acute phase reactant—normal or elevated levels don't exclude hemolysis during inflammation. Genetic ahaptoglobinemia exists (2% of African Americans).

Kappa/Lambda Ratio (Free Light Chains)

Autoimmune

Also known as: Kappa Lambda Ratio, Kappa Light Chain, What Causes Elevated Kappa Free Light Chains

Normal ratio: 0.26-1.65

Free light chains (kappa and lambda) are immunoglobulin fragments produced by plasma cells. Normally, kappa slightly exceeds lambda. A skewed ratio indicates monoclonal plasma cell proliferation—one type of light chain is produced in excess. Free light chain assay is more sensitive than serum protein electrophoresis for detecting plasma cell disorders.

Clinical Significance

Abnormal kappa/lambda ratio suggests multiple myeloma, AL amyloidosis, or light chain deposition disease. Ratio <0.26 (lambda excess) or >1.65 (kappa excess) warrants hematology referral. In renal failure, ratio changes—use renal-adjusted reference range. Free light chains also monitor treatment response in plasma cell dyscrasias.

Tumor Markers

10+ markers

PSA (Prostate-Specific Antigen)

Tumor Marker
Age-adjusted: <2.5 ng/mL (40-49yo) to <6.5 ng/mL (70-79yo)

PSA is a protein produced by prostate cells, used for prostate cancer screening and monitoring. Elevated PSA can result from cancer, benign prostatic hyperplasia (BPH), prostatitis, or recent ejaculation. PSA density, velocity, and free/total ratio help distinguish cancer from benign causes.

Clinical Significance

PSA >4 ng/mL traditionally prompts biopsy consideration, but 75% of biopsies are negative. Free PSA <10% suggests cancer; >25% suggests BPH. PSA velocity >0.75 ng/mL/year is concerning. After prostatectomy, PSA should be undetectable—any rise suggests recurrence. Discuss screening risks/benefits with men 55-69.

AFP (Alpha-Fetoprotein)

Tumor Marker

Also known as: AFP Blood Test, AFP Protein Test

Normal: <10 ng/mL (adults, non-pregnant)

AFP is a fetal protein that should be minimal in healthy adults. It's a tumor marker for hepatocellular carcinoma (HCC) and certain germ cell tumors (testicular, ovarian). AFP is also used for prenatal screening—elevated maternal AFP suggests neural tube defects; low AFP suggests Down syndrome risk.

Clinical Significance

AFP >400 ng/mL with liver mass is diagnostic of HCC without biopsy. AFP >20 ng/mL in cirrhotic patients warrants imaging for HCC surveillance. AFP is elevated in testicular nonseminomatous germ cell tumors—used for diagnosis, staging, and monitoring treatment response. Hepatitis and cirrhosis can mildly elevate AFP.

CA-125

Tumor Marker
Normal: <35 U/mL

CA-125 is a protein produced by various tissues including ovarian epithelium. It's primarily used to monitor ovarian cancer treatment response and detect recurrence. CA-125 is not recommended for screening due to poor specificity—elevated in many benign conditions including endometriosis, fibroids, pregnancy, and menstruation.

Clinical Significance

CA-125 >35 U/mL in postmenopausal women with pelvic mass has higher predictive value than in premenopausal women. For known ovarian cancer, CA-125 monitors treatment—50% decline indicates response. Rising CA-125 after treatment suggests recurrence, often 3-6 months before clinical detection. Not useful for screening.

CEA (Carcinoembryonic Antigen)

Tumor Marker
Normal: <3.0 ng/mL (non-smokers) | <5.0 ng/mL (smokers)

CEA is a glycoprotein involved in cell adhesion, normally produced during fetal development. In adults, it's used primarily to monitor colorectal cancer treatment and detect recurrence. CEA can also be elevated in other cancers (lung, breast, pancreatic) and benign conditions (smoking, IBD, cirrhosis).

Clinical Significance

Not useful for screening due to poor sensitivity/specificity. Baseline CEA before colorectal cancer treatment helps interpretation of post-treatment levels. Rising CEA after curative surgery suggests recurrence—may prompt imaging. CEA >20 ng/mL strongly suggests metastatic disease. Smoking can elevate CEA 2-3x.

CA 19-9

Tumor Marker
Normal: <37 U/mL

CA 19-9 is a carbohydrate antigen used primarily for pancreatic cancer diagnosis and monitoring. It's also elevated in other GI cancers (biliary, gastric, colorectal) and benign conditions (pancreatitis, biliary obstruction, cirrhosis). About 5-10% of people are Lewis antigen negative and cannot produce CA 19-9.

Clinical Significance

CA 19-9 >37 U/mL has 70-90% sensitivity for pancreatic cancer but poor specificity. Very high levels (>1000 U/mL) suggest advanced/metastatic disease. Falling CA 19-9 with treatment indicates response. Biliary obstruction alone can elevate CA 19-9—interpret with caution. Not recommended for screening.

Urinalysis Biomarkers

15+ markers

Urine pH

Urinalysis

Also known as: pH of Pee, pH of Urine

Normal: 4.5-8.0 (average 6.0)

Urine pH reflects the kidney's role in maintaining acid-base balance. The kidneys excrete hydrogen ions and reabsorb bicarbonate to regulate blood pH. Urine pH varies with diet (meat acidifies, vegetables alkalize), medications, and metabolic conditions. Persistently abnormal pH can promote kidney stone formation.

Clinical Significance

Persistently alkaline urine (pH >7) suggests UTI with urease-producing bacteria (Proteus), renal tubular acidosis, or vegetarian diet. Very acidic urine (pH <5.5) occurs with metabolic acidosis, starvation, or high-protein diet. Uric acid stones form in acidic urine; struvite stones in alkaline urine.

Urine Protein (Proteinuria)

Urinalysis

Also known as: Foamy Urine Meaning, Foaming Urine in Men/Women

Normal: Negative/Trace (<150 mg/day)

Healthy kidneys prevent protein loss in urine. Proteinuria indicates glomerular damage (leaking albumin) or tubular damage (failing to reabsorb filtered proteins). Foamy urine often indicates significant proteinuria. Proteinuria is a key marker of kidney disease progression and cardiovascular risk.

Clinical Significance

Trace proteinuria may be benign (exercise, fever, dehydration). Persistent proteinuria warrants quantification (spot urine albumin/creatinine ratio or 24-hour collection). Nephrotic-range proteinuria (>3.5 g/day) causes edema, hyperlipidemia, and thrombosis risk. ACE inhibitors reduce proteinuria and slow CKD progression.

Urine Nitrites

Urinalysis

Also known as: Nitrite in Urine Indicates

Normal: Negative

Nitrites in urine indicate the presence of bacteria that convert dietary nitrates to nitrites—primarily Gram-negative organisms like E. coli, Proteus, and Klebsiella. Nitrite testing requires urine to remain in the bladder for several hours for bacterial conversion, so early morning specimens are best.

Clinical Significance

Positive nitrites strongly suggest UTI (high specificity), but negative result doesn't exclude UTI (low sensitivity). Some bacteria (Enterococcus, Staphylococcus) don't produce nitrites. False negatives occur with dilute urine, frequent voiding, or low dietary nitrates. Confirm with urine culture if symptomatic.

Amorphous Crystals in Urine

Urinalysis
Normal: May be present (often not clinically significant)

Amorphous crystals are shapeless granular material found in urine sediment. Amorphous urates form in acidic urine (pink-tan color); amorphous phosphates form in alkaline urine (white). They're usually not clinically significant and often result from refrigeration of urine samples or concentrated urine.

Clinical Significance

Amorphous crystals are generally benign and don't indicate kidney disease. However, their presence may reflect urine concentration or pH that could predispose to certain stone types. Specific crystal types (calcium oxalate, uric acid, cystine, struvite) are more clinically significant for kidney stone disease.

Immature Granulocytes (IG)

CBC
Normal: <0.5% or <0.03 × 10⁹/L

Immature granulocytes include metamyelocytes, myelocytes, and promyelocytes—precursors to neutrophils normally found in bone marrow. Their presence in peripheral blood indicates accelerated neutrophil production, typically in response to severe infection, inflammation, or bone marrow disorders.

Clinical Significance

Elevated IG ("left shift") suggests severe bacterial infection, sepsis, or leukemia. In sepsis, IG >3% predicts worse outcomes. IG can rise before WBC in early infection. Chronic elevation may indicate myeloproliferative disorder.

Nucleated Red Blood Cells (nRBC)

CBC
Normal: 0 (absent in healthy adults)

Nucleated RBCs are immature red cells with retained nuclei that should be absent in adult peripheral blood. Their presence indicates severe stress on erythropoiesis, bone marrow infiltration, or extramedullary hematopoiesis. Normal in newborns but pathological in adults.

Clinical Significance

nRBCs in adults suggest severe anemia, hemolysis, bone marrow infiltration (myelophthisis), severe hypoxia, or sepsis. Associated with poor ICU outcomes. Can falsely elevate WBC count if not corrected.

Absolute Neutrophil Count (ANC)

CBC
Normal: 2,500-7,000 cells/μL

ANC represents the actual number of neutrophils calculated from WBC and differential. It's the key measure for assessing infection risk in neutropenic patients. ANC = WBC × (% neutrophils + % bands) / 100.

Clinical Significance

ANC <1,500 = neutropenia; <500 = severe neutropenia with high infection risk; <100 = profound neutropenia requiring protective isolation. Febrile neutropenia (fever + ANC <500) is a medical emergency requiring broad-spectrum antibiotics.

Absolute Lymphocyte Count (ALC)

CBC
Normal: 1,000-4,000 cells/μL

ALC is the absolute number of lymphocytes in blood, critical for assessing immune function. It includes T-cells, B-cells, and NK cells. ALC is used in HIV monitoring and as a prognostic marker in various conditions.

Clinical Significance

ALC <1,000 = lymphopenia, common in HIV, autoimmune diseases, and immunosuppression. In COVID-19, ALC <800 predicted worse outcomes. Persistent ALC >5,000 in adults suggests chronic lymphocytic leukemia.

Anion Gap

Metabolic
Normal: 8-12 mEq/L (without potassium)

Anion gap (AG) = Na - (Cl + HCO3) represents unmeasured anions in blood. It helps classify metabolic acidosis into high AG (presence of unmeasured acids) and normal AG (loss of bicarbonate) types.

Clinical Significance

High AG acidosis (AG >12): MUDPILES - Methanol, Uremia, DKA, Propylene glycol, Iron/Isoniazid, Lactic acidosis, Ethylene glycol, Salicylates. Normal AG acidosis: diarrhea, RTA, saline infusion. Always calculate AG with any metabolic acidosis.

Osmolality (Serum)

Metabolic
Normal: 280-295 mOsm/kg

Serum osmolality measures the concentration of dissolved particles. It's tightly regulated and primarily determined by sodium. Calculated osmolality = 2(Na) + Glucose/18 + BUN/2.8. The osmolar gap (measured - calculated) detects unmeasured osmoles.

Clinical Significance

Osmolar gap >10 suggests presence of unmeasured osmoles: ethanol, methanol, ethylene glycol, isopropanol, mannitol. High serum osmolality causes cell shrinkage; low osmolality causes cell swelling. Osmolality guides treatment of hypo/hypernatremia.

Lactate (Lactic Acid)

Metabolic
Normal: 0.5-2.0 mmol/L

Lactate is produced during anaerobic metabolism when oxygen delivery is insufficient. It's a critical marker of tissue hypoperfusion in shock and sepsis. Type A lactic acidosis results from tissue hypoxia; Type B from metabolic derangements without hypoxia.

Clinical Significance

Lactate >2 mmol/L in sepsis indicates organ dysfunction and increased mortality. Lactate >4 mmol/L indicates severe sepsis. Serial lactate monitoring (lactate clearance) guides resuscitation—failure to clear by 10% in 6 hours predicts poor outcome.

VLDL Cholesterol

Lipid
Normal: 5-40 mg/dL (calculated as TG/5)

VLDL (Very Low-Density Lipoprotein) carries triglycerides from liver to tissues. It's a precursor to LDL and is atherogenic. VLDL is usually calculated from triglycerides (TG/5) rather than directly measured.

Clinical Significance

Elevated VLDL contributes to cardiovascular risk and is included in non-HDL cholesterol calculations. VLDL remnants are highly atherogenic. Treatment targets triglycerides and underlying causes (obesity, diabetes, alcohol).

Remnant Cholesterol

Lipid
Optimal: <30 mg/dL

Remnant cholesterol (calculated as TC - LDL - HDL or non-fasting TG/5) represents triglyceride-rich lipoprotein remnants that are highly atherogenic. Unlike LDL, remnants can directly enter arterial walls without oxidation, making them particularly dangerous.

Clinical Significance

Elevated remnant cholesterol independently predicts cardiovascular disease beyond LDL-C. Particularly important in metabolic syndrome where LDL may appear normal while remnants are elevated. Targets lifestyle modification and triglyceride reduction.

Indirect Bilirubin

Liver
Normal: 0.1-0.8 mg/dL (calculated: Total - Direct)

Indirect (unconjugated) bilirubin is water-insoluble, bound to albumin, and cannot be excreted in urine. It's elevated when bilirubin production exceeds liver's conjugating capacity (hemolysis) or when conjugation is impaired (Gilbert syndrome, liver disease).

Clinical Significance

Isolated indirect hyperbilirubinemia with normal LFTs suggests hemolysis (check LDH, haptoglobin, reticulocytes) or Gilbert syndrome (benign, affects 5-10%). Very high indirect bilirubin can cross blood-brain barrier in neonates causing kernicterus.

A/G Ratio (Albumin/Globulin)

Liver
Normal: 1.1-2.5

The albumin/globulin ratio reflects the balance between liver-produced albumin and immune-produced globulins. Ratio changes help identify liver disease (low albumin), immune disorders (high globulins), or both.

Clinical Significance

Low A/G ratio (<1.0) suggests chronic liver disease, nephrotic syndrome, or hypergammaglobulinemia (multiple myeloma, chronic infections, autoimmune diseases). High A/G ratio is less common, may indicate immunodeficiency or acute stress response.

AST/ALT Ratio

Liver
Normal: 0.8-1.0 | Alcoholic: >2.0

The AST/ALT ratio helps differentiate causes of liver disease. In most liver diseases, ALT exceeds AST (ratio <1). Alcoholic liver disease typically shows AST > ALT with ratio >2, due to alcohol depleting pyridoxal phosphate needed for ALT activity.

Clinical Significance

Ratio >2 with AST <300: highly suggestive of alcoholic hepatitis. Ratio <1: typical of viral hepatitis, NAFLD. Ratio approaches 1 in cirrhosis of any cause. Very high AST with muscle symptoms suggests non-hepatic source (check CK).

Total T4 (Thyroxine)

Thyroid
Normal: 4.5-12.5 μg/dL

Total T4 measures both bound and free thyroxine. Since 99.97% of T4 is protein-bound (mainly to TBG), total T4 is affected by conditions altering binding proteins. Free T4 is generally preferred, but total T4 remains useful in some contexts.

Clinical Significance

Elevated TBG (pregnancy, estrogen, liver disease) raises total T4 without hyperthyroidism. Low TBG (androgens, nephrotic syndrome, severe illness) lowers total T4 without hypothyroidism. Free T4 avoids these confounders.

Total T3 (Triiodothyronine)

Thyroid
Normal: 80-200 ng/dL

Total T3 includes both bound and free forms of the most active thyroid hormone. T3 is affected by the same binding protein changes as T4. Total T3 is useful when T3 toxicosis is suspected (elevated T3 with normal T4).

Clinical Significance

T3 toxicosis (elevated T3, normal/low T4, suppressed TSH) occurs in early Graves' disease and toxic nodules. In sick euthyroid syndrome, T3 drops first as peripheral conversion decreases. Don't check T3 for hypothyroidism diagnosis.

Reverse T3 (rT3)

Thyroid
Normal: 10-24 ng/dL

Reverse T3 is an inactive metabolite of T4 produced when the body shifts T4 metabolism away from active T3. Elevated rT3 occurs in illness, calorie restriction, and stress as a protective mechanism to reduce metabolic rate.

Clinical Significance

High rT3 with low T3 (low T3 syndrome) occurs in non-thyroidal illness—thyroid hormone replacement generally not beneficial. Some use rT3 to explain persistent hypothyroid symptoms with normal TSH, but this interpretation is controversial.

Thyroglobulin (Tg)

Thyroid
Post-thyroidectomy: <0.1-0.5 ng/mL (undetectable)

Thyroglobulin is a protein produced only by thyroid tissue. After thyroidectomy for thyroid cancer, Tg serves as a tumor marker—any detectable level suggests residual or recurrent disease. Thyroglobulin antibodies can interfere with measurement.

Clinical Significance

Rising Tg after thyroid cancer treatment indicates recurrence. Stimulated Tg (after TSH withdrawal or rhTSH) is more sensitive than unstimulated. Always check anti-Tg antibodies—if positive, Tg may be falsely low.

TSI (Thyroid Stimulating Immunoglobulin)

Thyroid
Normal: <1.3 TSI Index or negative

TSI are antibodies that stimulate TSH receptors, causing hyperthyroidism in Graves' disease. They're specific for Graves' (not found in toxic nodular goiter) and help predict fetal/neonatal thyroid disease in pregnant women with Graves' history.

Clinical Significance

Positive TSI confirms Graves' disease when diagnosis unclear. In pregnancy, high TSI (especially >3x normal) can cross placenta and cause fetal/neonatal hyperthyroidism. Monitor TSI in Graves' to predict relapse after antithyroid drug withdrawal.

Creatinine Clearance

Kidney
Normal: 90-140 mL/min (men) | 80-125 mL/min (women)

Creatinine clearance estimates GFR using 24-hour urine creatinine and serum creatinine. It's more accurate than serum creatinine alone but requires complete urine collection. Calculated as (Urine Cr × Urine volume) / (Serum Cr × time).

Clinical Significance

24-hour CrCl is useful when eGFR equations may be inaccurate (extremes of muscle mass, amputation, unusual diet). CrCl slightly overestimates GFR due to tubular creatinine secretion. For chemotherapy dosing, some protocols require measured CrCl.

Urine Albumin/Creatinine Ratio (UACR)

Kidney
Normal: <30 mg/g | Microalbuminuria: 30-300 | Macroalbuminuria: >300

UACR quantifies urine albumin adjusted for urine concentration using creatinine. It's the preferred method for detecting early diabetic nephropathy and CKD. Random spot urine is convenient and correlates well with 24-hour collections.

Clinical Significance

UACR >30 mg/g is abnormal and independently predicts cardiovascular events and CKD progression. ACE inhibitors/ARBs reduce albuminuria and slow CKD progression. Check annually in diabetes and hypertension. SGLT2 inhibitors also reduce albuminuria.

Protein/Creatinine Ratio (UPCR)

Kidney
Normal: <150-200 mg/g | Nephrotic: >3,500 mg/g

UPCR measures total urine protein (not just albumin) adjusted for concentration. It detects both glomerular (albumin) and tubular (low molecular weight proteins) proteinuria. UPCR in mg/g approximates 24-hour protein in grams.

Clinical Significance

UPCR >3,500 mg/g (3.5 g/day) defines nephrotic-range proteinuria. In non-diabetic CKD, UPCR may be preferred over UACR as it captures tubular proteinuria. Monitoring UPCR helps assess treatment response in glomerulonephritis.

NT-proBNP

Cardiac
Rule-out acute HF: <300 pg/mL | Age-adjusted: <450/900/1800 pg/mL

NT-proBNP is the inactive N-terminal fragment cleaved from proBNP. It has a longer half-life than BNP (120 vs 20 minutes) resulting in higher levels. NT-proBNP and BNP are not interchangeable but serve similar diagnostic purposes.

Clinical Significance

NT-proBNP <300 pg/mL rules out acute HF. Age-adjusted rule-out: <450 (under 50), <900 (50-75), <1800 (over 75) pg/mL. NT-proBNP rises more with renal impairment than BNP. Serial NT-proBNP guides HF management—30% reduction indicates treatment response.

Troponin T (hs-TnT)

Cardiac
Normal: <14 ng/L (high-sensitivity)

Troponin T is a cardiac structural protein that, along with Troponin I, is the gold standard for myocardial injury detection. High-sensitivity assays detect very low levels, enabling earlier MI detection but also detecting chronic elevations in stable cardiac conditions.

Clinical Significance

Rising and/or falling pattern with at least one value above 99th percentile (14 ng/L) plus ischemic symptoms or ECG changes diagnoses MI. Chronic stable elevation (common in CKD, stable HF) indicates structural heart disease but not acute MI.

Homocysteine

Cardiac
Normal: 5-15 μmol/L

Homocysteine is an amino acid metabolite whose levels depend on vitamins B12, B6, and folate. Elevated homocysteine is associated with cardiovascular disease, stroke, and venous thrombosis, though treating with B vitamins hasn't reduced events in trials.

Clinical Significance

Elevated homocysteine (>15 μmol/L) warrants checking B12, folate, and kidney function. Very high levels (>100) suggest homocystinuria. Treatment with B vitamins lowers homocysteine but hasn't reduced cardiovascular events in trials. Check in young patients with unexplained thrombosis.

Vitamin A (Retinol)

Vitamins
Normal: 30-80 μg/dL (1.05-2.80 μmol/L)

Vitamin A is essential for vision, immune function, skin health, and cellular differentiation. It's fat-soluble and stored in the liver. Deficiency causes night blindness and xerophthalmia; excess causes hepatotoxicity and teratogenicity.

Clinical Significance

Deficiency rare in developed countries except with malabsorption or liver disease. Vitamin A toxicity occurs with chronic intake >25,000 IU/day. In pregnancy, retinol >10,000 IU/day is teratogenic—use beta-carotene instead.

Vitamin E (Alpha-Tocopherol)

Vitamins
Normal: 5.5-17 mg/L (12-40 μmol/L)

Vitamin E is a fat-soluble antioxidant that protects cell membranes from oxidative damage. Deficiency is rare except in severe fat malabsorption (cystic fibrosis, cholestasis) and causes neurological problems including ataxia and peripheral neuropathy.

Clinical Significance

Deficiency causes spinocerebellar ataxia, peripheral neuropathy, and hemolytic anemia. Check vitamin E in malabsorption syndromes. High-dose supplementation (>400 IU/day) may increase mortality and should be avoided.

Vitamin B6 (Pyridoxine)

Vitamins
Normal: 5-50 ng/mL (pyridoxal 5-phosphate)

Vitamin B6 is a cofactor for over 100 enzymes, including those involved in amino acid metabolism, neurotransmitter synthesis, and heme production. Deficiency causes peripheral neuropathy, dermatitis, and microcytic anemia; excess causes sensory neuropathy.

Clinical Significance

Deficiency common with isoniazid (give prophylactic B6), alcoholism, and malnutrition. Paradoxically, excess B6 (>200 mg/day chronic) causes sensory neuropathy indistinguishable from deficiency. Required for proper AST function—low B6 may lower AST.

Copper (Serum)

Vitamins
Normal: 70-150 μg/dL

Copper is essential for iron metabolism, connective tissue formation, and neurological function. Copper circulates bound to ceruloplasmin. Wilson disease causes copper accumulation due to impaired biliary excretion; Menkes disease causes deficiency from impaired absorption.

Clinical Significance

In Wilson disease, serum copper and ceruloplasmin are usually LOW (copper trapped in tissues), but free copper is elevated. Check 24-hour urine copper and ceruloplasmin to diagnose. Copper deficiency causes anemia, neutropenia, and myelopathy (mimics B12 deficiency).

Selenium

Vitamins
Normal: 70-150 μg/L

Selenium is a trace element essential for antioxidant enzymes (glutathione peroxidases) and thyroid hormone metabolism. Deficiency causes cardiomyopathy (Keshan disease) and muscle weakness. Selenium is important for thyroid function and immune response.

Clinical Significance

Deficiency occurs with TPN without supplementation, malabsorption, and dialysis. Low selenium may worsen hypothyroidism and autoimmune thyroiditis. Supplementation in autoimmune thyroiditis may reduce TPO antibodies. Excess (>400 μg/day) causes selenosis (GI, neuro, hair/nail changes).

Methylmalonic Acid (MMA)

Vitamins
Normal: <0.4 μmol/L (<271 nmol/L)

MMA is a metabolite that accumulates when vitamin B12-dependent methylmalonyl-CoA mutase is impaired. Elevated MMA is a sensitive and specific marker of functional B12 deficiency, elevated even when serum B12 is borderline or normal.

Clinical Significance

Elevated MMA with normal/borderline B12 confirms tissue B12 deficiency. MMA distinguishes B12 from folate deficiency (MMA normal in folate deficiency). Renal failure elevates MMA, reducing specificity. Combined with homocysteine for comprehensive assessment.

Free Testosterone

Hormones
Normal: 50-210 pg/mL (men) | 1-8.5 pg/mL (women)

Free testosterone is the unbound, biologically active fraction (~2% of total). Conditions affecting SHBG (sex hormone-binding globulin) can cause discordance between total and free testosterone. Free testosterone better reflects androgen status when SHBG is abnormal.

Clinical Significance

Check free testosterone when total is borderline or SHBG-altering conditions present (obesity lowers SHBG, aging increases it). Calculated free testosterone using total T, SHBG, and albumin is more accurate than direct immunoassay for free T.

SHBG (Sex Hormone-Binding Globulin)

Hormones
Normal: 10-57 nmol/L (men) | 18-144 nmol/L (women)

SHBG is a liver-produced protein that binds testosterone and estradiol, regulating the amount available to tissues. SHBG levels are affected by many factors: increased by estrogen, thyroid hormone, liver disease; decreased by obesity, insulin resistance, androgens.

Clinical Significance

Low SHBG (obesity, PCOS, hypothyroidism) increases free testosterone—may cause symptoms despite normal total T. High SHBG (hyperthyroidism, liver disease, aging) decreases free testosterone—may cause symptoms despite normal total T. Essential for interpreting testosterone results.

Progesterone

Hormones
Luteal phase: 5-20 ng/mL | Follicular: <1.5 ng/mL

Progesterone is produced by the corpus luteum after ovulation and by the placenta during pregnancy. It prepares the endometrium for implantation and maintains early pregnancy. Progesterone testing confirms ovulation and assesses luteal phase function.

Clinical Significance

Mid-luteal progesterone >3 ng/mL confirms ovulation. Levels >10 ng/mL indicate adequate luteal phase. Low progesterone in early pregnancy may indicate ectopic or non-viable pregnancy. Check day 21 (or 7 days post-ovulation) of cycle.

AMH (Anti-Müllerian Hormone)

Hormones
Normal: 1.0-3.5 ng/mL (reproductive age) | declines with age

AMH is produced by ovarian follicles and reflects ovarian reserve. Unlike FSH and estradiol, AMH is stable throughout the menstrual cycle and can be measured any day. Low AMH indicates diminished ovarian reserve; very high AMH suggests PCOS.

Clinical Significance

AMH <1.0 ng/mL suggests diminished ovarian reserve and reduced response to fertility treatment. AMH >3.5 ng/mL suggests PCOS if clinical features present. AMH declines with age and is undetectable after menopause. Useful for IVF planning and fertility counseling.

Growth Hormone (GH)

Hormones
Fasting random: <5 ng/mL (varies with pulsatile secretion)

Growth hormone is released in pulses from the pituitary, primarily during sleep. Random GH levels are difficult to interpret due to pulsatile secretion. GH deficiency is diagnosed with stimulation testing; excess (acromegaly) with suppression testing and IGF-1.

Clinical Significance

Random GH is not diagnostic—use IGF-1 for screening. GH deficiency confirmed by failed response to stimulation tests (insulin, glucagon, GHRH-arginine). Acromegaly: GH >1 ng/mL after oral glucose load (normally suppressed <0.4 ng/mL). GH nadir during OGTT is the diagnostic test.

ACTH (Adrenocorticotropic Hormone)

Hormones
AM (8am): 10-60 pg/mL

ACTH is produced by the pituitary to stimulate adrenal cortisol production. ACTH follows circadian rhythm (highest in morning). Combined with cortisol, ACTH differentiates primary adrenal disease (high ACTH, low cortisol) from pituitary/hypothalamic causes (low ACTH).

Clinical Significance

High ACTH + low cortisol = primary adrenal insufficiency (Addison's). Low ACTH + low cortisol = secondary (pituitary) insufficiency. High ACTH + high cortisol = ACTH-dependent Cushing's (pituitary adenoma or ectopic). Low ACTH + high cortisol = ACTH-independent Cushing's (adrenal tumor).

Sodium (Na)

Metabolic
Normal: 136-145 mEq/L

Sodium is the primary extracellular cation, essential for fluid balance, nerve function, and muscle contraction. Kidneys tightly regulate sodium levels. Abnormalities reflect water balance disorders more often than sodium intake problems.

Clinical Significance

Hyponatremia (<135): SIADH, heart failure, cirrhosis, diuretics. Severe (<120) causes seizures. Hypernatremia (>145): dehydration, diabetes insipidus. Correct slowly to prevent osmotic demyelination.

Potassium (K)

Metabolic
Normal: 3.5-5.0 mEq/L

Potassium is the primary intracellular cation, critical for cardiac conduction, muscle function, and cellular metabolism. Small changes in serum potassium significantly affect heart rhythm. Kidneys regulate potassium excretion.

Clinical Significance

Hypokalemia (<3.5): diuretics, vomiting, diarrhea—causes arrhythmias, weakness. Hyperkalemia (>5.5): renal failure, ACE inhibitors, cell lysis—life-threatening arrhythmias. Check ECG if K+ >6.0 or <2.5.

Chloride (Cl)

Metabolic
Normal: 98-106 mEq/L

Chloride is the major extracellular anion, closely linked to sodium. It helps maintain electroneutrality and acid-base balance. Chloride typically moves in the opposite direction of bicarbonate.

Clinical Significance

Hypochloremia: vomiting (loss of HCl), metabolic alkalosis, diuretics. Hyperchloremia: normal saline excess, diarrhea (loss of HCO3), RTA. Useful for calculating anion gap and identifying acid-base disorders.

Bicarbonate (HCO3/CO2)

Metabolic
Normal: 22-29 mEq/L

Bicarbonate is the body's primary buffer, maintaining blood pH between 7.35-7.45. The metabolic component of acid-base balance. On chemistry panels, "CO2" actually measures total CO2, mostly bicarbonate.

Clinical Significance

Low HCO3 (<22): metabolic acidosis (DKA, lactic acidosis, RTA, diarrhea). High HCO3 (>29): metabolic alkalosis (vomiting, diuretics) or compensation for respiratory acidosis. Always correlate with ABG.

Calcium (Total)

Metabolic
Normal: 8.5-10.5 mg/dL

Calcium is essential for bone health, muscle contraction, nerve function, and coagulation. About 40% is protein-bound (mainly albumin), so correct for albumin: Corrected Ca = Total Ca + 0.8 × (4 - albumin).

Clinical Significance

Hypercalcemia: hyperparathyroidism, malignancy (90% of cases), granulomatous disease. Hypocalcemia: hypoparathyroidism, vitamin D deficiency, renal failure. Symptoms: "bones, stones, groans, moans" (high Ca) vs tetany, seizures (low Ca).

Ionized Calcium

Metabolic
Normal: 4.5-5.3 mg/dL (1.12-1.32 mmol/L)

Ionized (free) calcium is the biologically active form, unaffected by albumin levels. More accurate than total calcium, especially in critically ill patients, those with abnormal proteins, or acid-base disturbances.

Clinical Significance

Preferred in ICU, surgery, and when albumin is abnormal. pH affects ionized calcium: alkalosis decreases ionized Ca (tetany despite normal total Ca); acidosis increases it. Critical values cause arrhythmias.

Magnesium (Mg)

Metabolic
Normal: 1.7-2.2 mg/dL

Magnesium is essential for 300+ enzymatic reactions, including ATP production, DNA synthesis, and neuromuscular function. Often overlooked but critically important. Hypomagnesemia causes refractory hypokalemia and hypocalcemia.

Clinical Significance

Hypomagnesemia: alcoholism, diuretics, malabsorption, PPIs—causes arrhythmias, seizures, refractory K+/Ca++ deficiency. Hypermagnesemia: renal failure, excess supplementation—causes weakness, respiratory depression. Check Mg in any refractory electrolyte disorder.

Phosphorus (Phosphate)

Metabolic
Normal: 2.5-4.5 mg/dL

Phosphorus is essential for ATP production, bone mineralization, and cellular signaling. Regulated by PTH, vitamin D, and FGF23. Inverse relationship with calcium. Major component of bone (85% of body phosphorus).

Clinical Significance

Hypophosphatemia: refeeding syndrome, alcoholism, DKA treatment, hyperparathyroidism—severe cases cause weakness, respiratory failure, hemolysis. Hyperphosphatemia: CKD, tumor lysis, hypoparathyroidism—precipitates with calcium causing soft tissue calcification.

Hemoglobin (Hgb)

CBC
Normal: 14-18 g/dL (men) | 12-16 g/dL (women)

Hemoglobin is the oxygen-carrying protein in red blood cells. It's the primary measure for diagnosing and classifying anemia. Hemoglobin determines oxygen delivery to tissues and is the main target for transfusion decisions.

Clinical Significance

Anemia: Hgb <12 g/dL (women), <14 g/dL (men). Severe anemia: <7-8 g/dL typically requires transfusion. Classify by MCV (microcytic, normocytic, macrocytic) and reticulocyte count. Polycythemia: Hgb >16.5 (women), >18.5 (men).

Hematocrit (HCT)

CBC
Normal: 40-54% (men) | 36-48% (women)

Hematocrit is the percentage of blood volume occupied by red blood cells. It roughly equals hemoglobin × 3. Affected by both RBC mass and plasma volume—dehydration falsely elevates HCT; overhydration falsely lowers it.

Clinical Significance

Low HCT: anemia, blood loss, hemolysis, overhydration. High HCT: polycythemia vera, dehydration, chronic hypoxia, EPO use. HCT >60% increases blood viscosity and thrombosis risk. Transfusion typically raises HCT by ~3% per unit.

Red Blood Cell Count (RBC)

CBC
Normal: 4.5-5.5 M/μL (men) | 4.0-5.0 M/μL (women)

RBC count measures the number of red blood cells per microliter of blood. Combined with hemoglobin and hematocrit, it helps characterize anemias. RBC count can be normal or elevated in some anemias with small cells (microcytic).

Clinical Significance

Low RBC: anemia from any cause. High RBC: polycythemia vera, secondary polycythemia (hypoxia, EPO). In thalassemia trait, RBC count is often normal or elevated despite low Hgb (many small cells). Calculate RBC indices for anemia workup.

White Blood Cell Count (WBC)

CBC
Normal: 4,500-11,000 cells/μL

WBC count measures total white blood cells, the immune system's cellular component. The differential breaks down WBC into neutrophils, lymphocytes, monocytes, eosinophils, and basophils—each with distinct functions and disease associations.

Clinical Significance

Leukocytosis (>11,000): infection, inflammation, stress, steroids, leukemia. Leukopenia (<4,500): viral infections, bone marrow failure, autoimmune, chemotherapy. Always check differential—the pattern matters more than total count.

Platelet Count (PLT)

CBC
Normal: 150,000-400,000/μL

Platelets are cell fragments essential for primary hemostasis (initial clot formation). Produced by megakaryocytes in bone marrow, with ~1/3 sequestered in spleen. Lifespan is 8-10 days. Both high and low counts carry clinical significance.

Clinical Significance

Thrombocytopenia (<150K): ITP, TTP/HUS, DIC, bone marrow failure, medications, liver disease. <50K increases surgical bleeding; <10K risks spontaneous bleeding. Thrombocytosis (>450K): reactive (infection, iron deficiency) or myeloproliferative.

Mean Platelet Volume (MPV)

CBC
Normal: 7.5-11.5 fL

MPV measures average platelet size. Young platelets are larger and more reactive. MPV helps distinguish causes of thrombocytopenia: high MPV suggests peripheral destruction (young platelets released); low MPV suggests bone marrow failure.

Clinical Significance

High MPV + low platelets: ITP, consumptive thrombocytopenia (active bone marrow response). Low MPV + low platelets: bone marrow failure, chemotherapy. High MPV alone: associated with cardiovascular risk and platelet activation.

Fasting Glucose

Metabolic
Normal: 70-99 mg/dL | Prediabetes: 100-125 | Diabetes: ≥126

Fasting glucose measures blood sugar after 8+ hours without eating. It's a primary screening test for diabetes. Glucose regulation involves insulin, glucagon, cortisol, and other hormones maintaining levels within narrow range.

Clinical Significance

Fasting glucose ≥126 mg/dL on two occasions diagnoses diabetes. 100-125 is prediabetes with 5-10% annual progression to diabetes. Hypoglycemia (<70): excess insulin, liver disease, adrenal insufficiency—symptoms below 55 mg/dL, seizures below 40.

HbA1c (Glycated Hemoglobin)

Metabolic
Normal: <5.7% | Prediabetes: 5.7-6.4% | Diabetes: ≥6.5%

HbA1c reflects average blood glucose over 2-3 months (RBC lifespan). Glucose non-enzymatically attaches to hemoglobin, and the percentage reflects glycemic exposure. HbA1c doesn't require fasting and has less day-to-day variability than glucose.

Clinical Significance

HbA1c ≥6.5% diagnoses diabetes; target <7% for most diabetics to reduce complications. Each 1% reduction decreases microvascular complications by ~35%. Inaccurate with hemoglobinopathies, hemolysis, recent transfusion, anemia, or ESRD.

BUN (Blood Urea Nitrogen)

Kidney
Normal: 7-20 mg/dL

BUN measures nitrogen from urea, a protein metabolism waste product. Produced in liver, filtered by kidneys. BUN is affected by protein intake, hydration status, and liver function, making it less specific for kidney function than creatinine.

Clinical Significance

High BUN: dehydration (prerenal), kidney disease (renal), obstruction (postrenal), GI bleeding, high protein intake, catabolic states. Low BUN: low protein intake, liver failure, overhydration. BUN/Creatinine ratio helps identify prerenal azotemia (>20:1).

Creatinine

Kidney
Normal: 0.7-1.3 mg/dL (men) | 0.6-1.1 mg/dL (women)

Creatinine is a muscle metabolism byproduct filtered by kidneys at a constant rate. More specific for kidney function than BUN as it's less affected by diet and hydration. Serum creatinine inversely relates to GFR—it rises as kidney function declines.

Clinical Significance

Creatinine increases only after significant GFR decline (~50%). Affected by muscle mass—low in elderly/cachexic, high in muscular individuals. Use eGFR equations (CKD-EPI) for accurate assessment. AKI: creatinine rise ≥0.3 mg/dL in 48 hours or ≥1.5x baseline in 7 days.

eGFR (Estimated GFR)

Kidney
Normal: >90 mL/min/1.73m² | CKD Stage 3: 30-59 | Stage 4: 15-29 | Stage 5: <15

eGFR estimates glomerular filtration rate from serum creatinine, age, and sex using validated equations (CKD-EPI 2021 removes race). It's the best overall measure of kidney function and determines CKD stage. eGFR guides drug dosing and predicts outcomes.

Clinical Significance

CKD defined as eGFR <60 for ≥3 months or kidney damage markers. Stage 3: requires monitoring, drug dose adjustment. Stage 4: prepare for renal replacement therapy. Stage 5 (<15): kidney failure, consider dialysis/transplant. NSAID, contrast, drug adjustments based on eGFR.

Total Cholesterol

Lipid
Desirable: <200 mg/dL | Borderline: 200-239 | High: ≥240

Total cholesterol includes LDL, HDL, and VLDL. While useful for initial screening, the individual components (especially LDL and non-HDL) better predict cardiovascular risk. Cholesterol is essential for cell membranes, hormones, and vitamin D synthesis.

Clinical Significance

Total cholesterol alone doesn't determine treatment—assess LDL, HDL, and triglycerides. Very low cholesterol (<160) may indicate malnutrition, hyperthyroidism, liver disease, or malignancy. Non-HDL cholesterol (TC - HDL) better captures atherogenic particles.

LDL Cholesterol

Lipid
Optimal: <100 mg/dL | High risk target: <70 | Very high risk: <55

LDL (Low-Density Lipoprotein) carries cholesterol to tissues and is the primary atherogenic lipoprotein. LDL particles penetrate arterial walls, become oxidized, and trigger plaque formation. LDL is the primary target for cardiovascular risk reduction.

Clinical Significance

LDL <70 mg/dL target for secondary prevention and high-risk patients (diabetes + additional risk). <55 mg/dL for very high risk (prior MI, multivessel CAD). Each 39 mg/dL LDL reduction decreases CV events by ~22%. Statins are first-line therapy.

HDL Cholesterol

Lipid
Desirable: >40 mg/dL (men) | >50 mg/dL (women) | Optimal: >60

HDL (High-Density Lipoprotein) performs "reverse cholesterol transport," carrying cholesterol from tissues back to liver for excretion. Epidemiologically protective against cardiovascular disease. However, raising HDL pharmacologically hasn't reduced events.

Clinical Significance

Low HDL (<40) is a cardiovascular risk factor. Exercise, moderate alcohol, and smoking cessation raise HDL. Niacin and CETP inhibitors raise HDL but don't reduce events—HDL function may matter more than levels. Very high HDL (>100) may not be protective.

Triglycerides

Lipid
Normal: <150 mg/dL | Borderline: 150-199 | High: 200-499 | Very high: ≥500

Triglycerides are fats from diet and liver synthesis, carried by VLDL and chylomicrons. Levels rise after eating (peak 4-6 hours). High triglycerides indicate metabolic syndrome and, at very high levels (>500), risk pancreatitis. Fasting sample preferred but non-fasting acceptable for initial screening.

Clinical Significance

TG >500 mg/dL: treat to prevent pancreatitis (fibrates, omega-3). TG 150-499: address lifestyle factors (weight loss, limit alcohol/carbs, exercise). Very high TG falsely lowers calculated LDL—request direct LDL. Low triglycerides (<50) rarely clinically significant.

ApoB (Apolipoprotein B)

Lipid
Desirable: <90 mg/dL | High risk: <80 | Very high risk: <65

ApoB is the protein component of all atherogenic lipoproteins (LDL, VLDL, IDL, Lp(a)). One ApoB per particle, so ApoB directly counts atherogenic particle number—a better predictor of cardiovascular risk than LDL-C, especially when LDL and TG levels discordant.

Clinical Significance

ApoB may be superior to LDL-C for risk assessment, particularly in metabolic syndrome where small dense LDL particles carry less cholesterol each. Discordance between ApoB and LDL-C (ApoB high, LDL-C normal) indicates increased risk. Some guidelines now include ApoB targets.

Lp(a) (Lipoprotein(a))

Lipid
Desirable: <30 mg/dL (or <75 nmol/L)

Lp(a) is an LDL-like particle with apolipoprotein(a) attached. Levels are 90% genetically determined and stable throughout life. Elevated Lp(a) is an independent, causal risk factor for ASCVD and aortic stenosis, affecting 20% of the population.

Clinical Significance

Check Lp(a) once in lifetime for risk stratification. No approved Lp(a)-lowering therapy yet (trials ongoing). High Lp(a) patients benefit from aggressive LDL lowering. Consider in unexplained premature ASCVD, family history, or risk refinement. Niacin modestly lowers Lp(a) but not recommended solely for this.

Non-HDL Cholesterol

Lipid
Target: LDL goal + 30 mg/dL (e.g., <130 if LDL goal <100)

Non-HDL cholesterol (Total cholesterol - HDL) captures all atherogenic lipoproteins including LDL, VLDL, IDL, and Lp(a). It's particularly useful when triglycerides are elevated, making calculated LDL less accurate. Can be measured non-fasting.

Clinical Significance

Non-HDL is the secondary treatment target after LDL. It's more predictive than LDL when triglycerides are elevated. Guidelines suggest non-HDL goal = LDL goal + 30 mg/dL. Useful for monitoring in metabolic syndrome and diabetes.

Procalcitonin (PCT)

Inflammatory
Normal: <0.1 ng/mL | Bacterial infection likely: >0.5

Procalcitonin is a peptide that rises specifically in bacterial infections and sepsis. Unlike CRP, PCT remains low in viral infections and non-infectious inflammation. This selectivity makes it useful for differentiating bacterial from viral infections and guiding antibiotic therapy.

Clinical Significance

PCT <0.25: bacterial infection unlikely, can withhold/stop antibiotics. PCT 0.25-0.5: bacterial infection possible. PCT >0.5: bacterial infection likely, antibiotics indicated. Serial PCT guides antibiotic duration—stopping when PCT falls <0.25 or decreases 80% is safe.

Interleukin-6 (IL-6)

Inflammatory
Normal: <7 pg/mL

IL-6 is a pro-inflammatory cytokine that drives the acute phase response, stimulating CRP production by the liver. It rises earlier than CRP in infection/inflammation. IL-6 is involved in cytokine storm and is a therapeutic target in COVID-19 and autoimmune diseases.

Clinical Significance

Very high IL-6 (>100 pg/mL) indicates severe inflammation, sepsis, or cytokine release syndrome. IL-6 inhibitors (tocilizumab) are used in rheumatoid arthritis and severe COVID-19. IL-6 independently predicts mortality in sepsis and COVID-19.

Ferritin (Inflammatory Marker)

Inflammatory
See Vitamins section for iron stores | Inflammatory: >500-1000 ng/mL concerning

While primarily an iron storage marker, ferritin is also an acute phase reactant that rises dramatically in inflammation, infection, and malignancy. Very high ferritin (>1000-10,000) suggests hemophagocytic lymphohistiocytosis (HLH), Adult-onset Still's disease, or severe systemic inflammation.

Clinical Significance

Ferritin >500 ng/mL in acute illness indicates significant inflammation—not iron overload. Ferritin >10,000 ng/mL strongly suggests HLH or Still's disease. In COVID-19, very high ferritin predicted worse outcomes. Interpret with CRP—both elevated = inflammation masking iron status.

Urine Specific Gravity

Urinalysis
Normal: 1.005-1.030

Specific gravity measures urine concentration relative to water (1.000). It reflects kidney's ability to concentrate or dilute urine. Depends on hydration status and kidney concentrating ability. Used to interpret other urinalysis findings and assess hydration.

Clinical Significance

Very dilute (<1.005): diabetes insipidus, overhydration, diuretics. Very concentrated (>1.030): dehydration, SIADH, contrast dye. Fixed at 1.010: renal tubular damage (can't concentrate or dilute). Affects interpretation of urine protein/cells—dilute urine gives false low values.

Urine Blood (Hematuria)

Urinalysis
Normal: Negative

Urine dipstick detects hemoglobin from intact RBCs (hematuria), free hemoglobin (hemolysis), or myoglobin (rhabdomyolysis). Microscopy distinguishes true hematuria (RBCs present) from hemoglobinuria/myoglobinuria (no RBCs). Hematuria can be glomerular or non-glomerular.

Clinical Significance

Microscopic hematuria (>3 RBC/HPF) requires evaluation: urinalysis, cytology, imaging, +/- cystoscopy to rule out malignancy. Dysmorphic RBCs and casts suggest glomerular origin. Positive dipstick without RBCs suggests hemoglobinuria or myoglobinuria—check serum CK for rhabdomyolysis.

Urine Leukocyte Esterase

Urinalysis
Normal: Negative

Leukocyte esterase is an enzyme released by white blood cells. Positive result indicates pyuria (WBCs in urine), suggesting urinary tract infection or inflammation. Combined with nitrites, it's useful for UTI screening, though culture remains the gold standard.

Clinical Significance

Positive LE + positive nitrites: 95% predictive of UTI. Positive LE alone: may be UTI, STI, interstitial nephritis, or contamination. Negative LE + negative nitrites in symptomatic patient: doesn't rule out UTI (low bacterial count, non-nitrite producers). Always correlate with symptoms.

Urine Glucose

Urinalysis
Normal: Negative

Glucose appears in urine when blood glucose exceeds renal threshold (~180 mg/dL) or tubular reabsorption is impaired. Historically used for diabetes monitoring before home glucose meters. Now mainly indicates uncontrolled hyperglycemia or renal tubular dysfunction.

Clinical Significance

Glucosuria with hyperglycemia: uncontrolled diabetes. Glucosuria with normal blood glucose: renal glucosuria (benign), Fanconi syndrome, SGLT2 inhibitors (intentional). Note: SGLT2 inhibitors cause intentional glucosuria for diabetes treatment—expected finding, not pathological.

Urine Ketones

Urinalysis
Normal: Negative

Ketones (acetoacetate, beta-hydroxybutyrate) appear in urine during fat metabolism when glucose is unavailable or unusable. Urine dipstick detects acetoacetate only; serum beta-hydroxybutyrate is more accurate for DKA. Ketonuria occurs with fasting, DKA, alcoholic ketoacidosis, and low-carb diets.

Clinical Significance

Large ketonuria + hyperglycemia = DKA until proven otherwise. Ketonuria without hyperglycemia: starvation ketosis, alcoholic ketoacidosis, ketogenic diet. During DKA treatment, urine ketones may persist (acetoacetate) while serum BHB falls—follow serum ketones, not urine.

Urine Bilirubin

Urinalysis
Normal: Negative

Only conjugated (direct) bilirubin is water-soluble and appears in urine. Unconjugated bilirubin is bound to albumin and doesn't pass into urine. Bilirubinuria indicates hepatobiliary disease with elevated conjugated bilirubin—never from hemolysis alone.

Clinical Significance

Positive urine bilirubin = hepatobiliary disease (hepatitis, obstruction, cholestasis). Dark "tea-colored" urine is visible bilirubinuria. Combined with urobilinogen helps classify jaundice: hemolytic (high urobilinogen, no bilirubin), hepatocellular (both present), obstructive (bilirubin only, no urobilinogen).

MCV (Mean Corpuscular Volume)

CBC
Normal: 80-100 fL

MCV measures average RBC volume, classifying anemias as microcytic (<80), normocytic (80-100), or macrocytic (>100). Key for anemia differential diagnosis. See our complete RDW guide for detailed interpretation.

Clinical Significance

Microcytic: iron deficiency, thalassemia. Macrocytic: B12/folate deficiency, liver disease, hypothyroidism. Combined with RDW provides powerful diagnostic classification.

MCH (Mean Corpuscular Hemoglobin)

CBC
Normal: 27-33 pg

MCH measures average hemoglobin mass per RBC. Low MCH indicates hypochromic cells (iron deficiency, thalassemia). MCH generally parallels MCV—small cells have less hemoglobin.

Clinical Significance

Low MCH (<27): iron deficiency, thalassemia, chronic disease. High MCH (>33): macrocytic anemias. MCH = Hgb/RBC × 10.

MCHC (Mean Corpuscular Hemoglobin Concentration)

CBC
Normal: 32-36 g/dL

MCHC is hemoglobin concentration per RBC volume. Low MCHC means hypochromic cells. MCHC rarely exceeds 36 g/dL (hemoglobin solubility limit) except in spherocytosis where cells are very small.

Clinical Significance

Low MCHC (<32): iron deficiency, thalassemia. High MCHC (>36): hereditary spherocytosis, cold agglutinins (artifact). See our RDW guide.

RDW (Red Cell Distribution Width)

CBC
Normal: 11.5-14.5%

RDW measures variation in RBC sizes (anisocytosis). High RDW indicates mixed cell populations. Combined with MCV, RDW helps differentiate anemia causes. Iron deficiency has high RDW; thalassemia trait has normal RDW.

Clinical Significance

High RDW + low MCV: iron deficiency (vs thalassemia trait with normal RDW). High RDW is also a cardiovascular and mortality predictor. Read our comprehensive RDW guide.

Reticulocyte Count

CBC
Normal: 0.5-2.5% or 25-75 × 10⁹/L (absolute)

Reticulocytes are immature RBCs just released from bone marrow. Reticulocyte count reflects bone marrow RBC production. Essential for classifying anemia as production problem vs destruction/loss problem.

Clinical Significance

High reticulocytes: appropriate response to hemolysis or blood loss (marrow working). Low reticulocytes in anemia: production problem (iron deficiency, B12 deficiency, bone marrow failure). Calculate reticulocyte production index for accuracy.

Neutrophils (Absolute)

CBC
Normal: 2,500-7,000 cells/μL (40-70%)

Neutrophils are the most abundant WBCs, first responders to bacterial infection. They phagocytose bacteria and release inflammatory mediators. "Left shift" means increased immature neutrophils (bands) indicating acute infection.

Clinical Significance

Neutrophilia: bacterial infection, steroids, stress, CML. Neutropenia: viral infections, drugs, autoimmune, chemo. ANC <500 = severe infection risk. Bandemia (>10% bands) indicates acute bacterial infection.

Lymphocytes (Absolute)

CBC
Normal: 1,000-4,000 cells/μL (20-40%)

Lymphocytes include T-cells (cellular immunity), B-cells (antibody production), and NK cells (innate immunity). Absolute count more meaningful than percentage. Flow cytometry further characterizes lymphocyte subsets.

Clinical Significance

Lymphocytosis: viral infections (EBV, CMV), CLL, pertussis. Lymphopenia: HIV, steroids, autoimmune, severe illness. CD4 count (T-helper) critical in HIV. ALC <1000 indicates significant immunocompromise.

Monocytes (Absolute)

CBC
Normal: 200-800 cells/μL (2-8%)

Monocytes are large WBCs that migrate to tissues and become macrophages. They phagocytose pathogens, present antigens, and regulate inflammation. Important in chronic infections like tuberculosis.

Clinical Significance

Monocytosis: chronic infections (TB, endocarditis), chronic inflammation (IBD, autoimmune), CMML, recovery phase of infection. Monocytopenia: bone marrow failure, hairy cell leukemia.

Eosinophils (Absolute)

CBC
Normal: 100-500 cells/μL (1-4%)

Eosinophils fight parasites and mediate allergic inflammation. They release granules containing cytotoxic proteins. Eosinophilia is defined as >500 cells/μL; severe eosinophilia >1500 can cause organ damage.

Clinical Significance

NAACP mnemonic: Neoplasm, Allergy/Asthma, Addison's, Collagen vascular disease, Parasites. Hypereosinophilia (>1500) may indicate hypereosinophilic syndrome with cardiac, pulmonary, and neurological complications.

Basophils (Absolute)

CBC
Normal: 0-200 cells/μL (0-1%)

Basophils are the rarest WBCs, containing histamine and heparin granules. They play roles in allergic reactions and parasitic immunity. Basophilia is often associated with myeloproliferative neoplasms.

Clinical Significance

Basophilia: CML (characteristic finding), other myeloproliferative neoplasms, allergic conditions, hypothyroidism. Isolated basophilia rare—consider CML workup. Basopenia has little clinical significance.

Direct Bilirubin (Conjugated)

Liver
Normal: 0.0-0.3 mg/dL

Direct (conjugated) bilirubin is water-soluble and can be excreted in urine. It's elevated in hepatocellular disease and biliary obstruction. Direct bilirubin >50% of total indicates hepatobiliary pathology rather than hemolysis.

Clinical Significance

Elevated direct bilirubin: bile duct obstruction, hepatitis, Dubin-Johnson/Rotor syndromes. Appears in urine (bilirubinuria) causing dark urine. Mixed hyperbilirubinemia common in liver disease.

Prealbumin (Transthyretin)

Liver
Normal: 20-40 mg/dL

Prealbumin (transthyretin) is a transport protein for thyroid hormone and vitamin A. With its short half-life (2 days), it responds quickly to nutritional changes, making it a marker of recent protein status and acute nutritional changes.

Clinical Significance

Low prealbumin: malnutrition, inflammation, liver disease. More sensitive to acute nutritional changes than albumin. However, inflammation (negative acute phase reactant) limits its specificity for malnutrition—interpret with CRP.

Ammonia

Liver
Normal: 15-45 μg/dL (11-32 μmol/L)

Ammonia is produced from protein metabolism and normally converted to urea by the liver. In liver failure, ammonia accumulates and crosses the blood-brain barrier, causing hepatic encephalopathy. Sample handling critical—process immediately on ice.

Clinical Significance

Elevated ammonia with altered mental status suggests hepatic encephalopathy. However, ammonia levels don't correlate well with encephalopathy severity—treat clinically. Also elevated in urea cycle disorders, GI bleeding, renal failure.

hCG (Human Chorionic Gonadotropin)

Tumor Marker
Non-pregnant: <5 mIU/mL | Pregnancy: varies by gestational age

hCG is produced by placental trophoblasts during pregnancy and by certain tumors (gestational trophoblastic disease, testicular germ cell tumors). Quantitative hCG is essential for early pregnancy monitoring and tumor marker surveillance.

Clinical Significance

Pregnancy: hCG doubles every 48-72 hours in early normal pregnancy. Ectopic pregnancy: abnormal rise. Tumor marker: elevated in choriocarcinoma, testicular cancer. Very high hCG (>100,000) suggests gestational trophoblastic disease.

CA 15-3

Tumor Marker
Normal: <30 U/mL

CA 15-3 is a mucin glycoprotein used to monitor breast cancer treatment response and detect recurrence. Not useful for screening due to low sensitivity in early disease. Elevated in metastatic breast cancer in 50-70% of cases.

Clinical Significance

Rising CA 15-3 may indicate breast cancer recurrence 5-6 months before clinical detection. Used for monitoring metastatic disease—falling levels indicate treatment response. Also elevated in benign breast disease, liver disease, other cancers.

CA 27.29

Tumor Marker
Normal: <38 U/mL

CA 27.29, like CA 15-3, is a mucin marker used in breast cancer monitoring. It detects the same MUC1 protein but with different epitopes. Either marker (not both) can be used for monitoring—similar clinical utility.

Clinical Significance

Used interchangeably with CA 15-3 for breast cancer monitoring. Rising levels may indicate recurrence or progression. Not recommended for screening. Interpret trends rather than single values.

Thrombin Time (TT)

Coagulation
Normal: 14-19 seconds

Thrombin time measures the final step of coagulation: thrombin converting fibrinogen to fibrin. It's independent of intrinsic and extrinsic pathways. Prolonged TT indicates fibrinogen problems or thrombin inhibition.

Clinical Significance

Prolonged TT: heparin contamination (most common), low fibrinogen, dysfibrinogenemia, fibrin degradation products, direct thrombin inhibitors (dabigatran). Very prolonged TT with heparin effect confirms heparin presence.

Antithrombin III (AT III)

Coagulation
Normal: 80-120%

Antithrombin is the main inhibitor of thrombin and factor Xa. It's essential for heparin's anticoagulant effect. AT deficiency is an inherited thrombophilia that causes venous thromboembolism, often in unusual sites.

Clinical Significance

Low AT: inherited deficiency, DIC, liver disease, nephrotic syndrome, heparin use, acute thrombosis (consumed). In AT deficiency, heparin may be less effective—use direct thrombin inhibitors. Test after acute event resolves.

Protein C

Coagulation
Normal: 70-140%

Protein C is a vitamin K-dependent anticoagulant that, when activated by thrombin-thrombomodulin, inactivates factors Va and VIIIa. Protein C deficiency increases VTE risk. Warfarin initially lowers Protein C, risking warfarin-induced skin necrosis.

Clinical Significance

Low Protein C: inherited deficiency, warfarin use, liver disease, DIC, acute thrombosis. Don't test during acute VTE or on warfarin. Severe homozygous deficiency causes neonatal purpura fulminans. Bridge with heparin when starting warfarin.

Protein S

Coagulation
Normal: 60-130% (total) | 57-101% (free)

Protein S is a vitamin K-dependent cofactor for activated Protein C. Only free Protein S (40%) is active; the rest binds C4b-binding protein. Protein S deficiency is an inherited thrombophilia. Estrogen lowers Protein S levels.

Clinical Significance

Low Protein S: inherited deficiency, warfarin, pregnancy/estrogen, acute inflammation (C4BP increases), liver disease, acute thrombosis. Test free Protein S when total is borderline. Don't test during pregnancy or on estrogen/warfarin.

Factor V Leiden

Coagulation
Normal: Negative (wild type)

Factor V Leiden is a genetic mutation making Factor V resistant to inactivation by activated Protein C. Most common inherited thrombophilia in Caucasians (5%). Heterozygotes have 5-10x VTE risk; homozygotes 50-100x risk.

Clinical Significance

Test after unprovoked VTE, VTE at young age, family history, or recurrent VTE. Doesn't change acute treatment but may influence duration. Combined with other risk factors (estrogen, travel) dramatically increases risk. Genetic test (DNA) or functional APC resistance test.

Anti-dsDNA (Double-Stranded DNA)

Autoimmune
Normal: <30 IU/mL (varies by assay)

Anti-dsDNA antibodies are highly specific (95%) for systemic lupus erythematosus. They correlate with disease activity, especially lupus nephritis. Rising titers often precede flares. Present in 50-70% of SLE patients.

Clinical Significance

Positive anti-dsDNA with positive ANA strongly supports SLE diagnosis. Titer correlates with disease activity—useful for monitoring. High anti-dsDNA with low complement predicts renal involvement. Rarely positive in other conditions.

Anti-Smith (Anti-Sm)

Autoimmune
Normal: Negative

Anti-Smith antibodies are highly specific (99%) for SLE but have low sensitivity (25-30%). They target snRNP proteins involved in mRNA processing. Unlike anti-dsDNA, anti-Sm titers don't correlate with disease activity.

Clinical Significance

Positive anti-Sm is virtually diagnostic of SLE—the most specific lupus antibody. Once positive, usually remains positive regardless of disease activity. Include in lupus workup but absence doesn't exclude SLE.

Anti-SSA (Ro) / Anti-SSB (La)

Autoimmune
Normal: Negative

Anti-SSA (Ro) and Anti-SSB (La) are extractable nuclear antigens found in Sjögren syndrome and SLE. Anti-SSA is more common and associated with neonatal lupus and congenital heart block when present in pregnant women.

Clinical Significance

Anti-SSA/SSB positive in 70%/40% of Sjögren's, 40%/15% of SLE. Pregnant women with anti-SSA: 2% risk of neonatal lupus, 2% risk of congenital heart block—requires fetal monitoring. "ANA-negative lupus" may have anti-SSA.

Anti-Scl-70 (Anti-Topoisomerase I)

Autoimmune
Normal: Negative

Anti-Scl-70 targets DNA topoisomerase I and is specific for systemic sclerosis (scleroderma), particularly diffuse cutaneous disease. Associated with increased risk of interstitial lung disease and more severe disease course.

Clinical Significance

Positive in 20-40% of systemic sclerosis, almost exclusively diffuse type. Predicts pulmonary fibrosis—screen with pulmonary function tests. Mutually exclusive with anticentromere antibodies. ANA pattern usually nucleolar.

Anticentromere Antibodies (ACA)

Autoimmune
Normal: Negative

Anticentromere antibodies target centromeric proteins and are highly specific for limited cutaneous systemic sclerosis (CREST syndrome). Associated with less severe skin and lung disease but increased pulmonary arterial hypertension risk.

Clinical Significance

Positive in 50-90% of limited scleroderma (CREST), rare in diffuse disease. Predicts pulmonary arterial hypertension—screen with echocardiography. Better prognosis than anti-Scl-70 positive disease. Distinctive ANA pattern with discrete speckles.

ANCA (Anti-Neutrophil Cytoplasmic Antibodies)

Autoimmune
Normal: Negative

ANCA are autoantibodies against neutrophil granule proteins. c-ANCA (cytoplasmic, anti-PR3) is associated with GPA (Wegener's); p-ANCA (perinuclear, anti-MPO) with MPA and EGPA. Essential for diagnosing ANCA-associated vasculitis.

Clinical Significance

c-ANCA/PR3: 90% specific for GPA, lung and kidney involvement common. p-ANCA/MPO: MPA, EGPA, also drug-induced vasculitis. Rising ANCA may predict relapse. Atypical p-ANCA seen in IBD. Always confirm IIF pattern with specific PR3/MPO ELISA.

Anti-GBM (Glomerular Basement Membrane)

Autoimmune
Normal: Negative (<20 EU)

Anti-GBM antibodies target the alpha-3 chain of type IV collagen in glomerular and alveolar basement membranes. They cause Goodpasture syndrome (pulmonary hemorrhage + rapidly progressive glomerulonephritis). A medical emergency requiring plasmapheresis.

Clinical Significance

Positive anti-GBM with pulmonary hemorrhage and/or RPGN = Goodpasture syndrome. Requires urgent treatment: plasmapheresis + immunosuppression. 30% have concurrent ANCA (double positive—worse prognosis). Kidney biopsy shows linear IgG staining.

Aldosterone

Hormones
Upright: 7-30 ng/dL | Supine: 3-16 ng/dL

Aldosterone is a mineralocorticoid produced by the adrenal zona glomerulosa. It regulates sodium retention and potassium excretion, controlled by RAAS. Aldosterone/renin ratio (ARR) screens for primary aldosteronism, the most common secondary hypertension cause.

Clinical Significance

ARR >30 (ng/dL:ng/mL/hr) with aldosterone >15: suggests primary aldosteronism. Confirm with salt loading test. Primary aldosteronism: high aldosterone, low renin. Secondary hyperaldosteronism: high aldosterone, high renin (renovascular HTN, CHF).

Renin (Plasma Renin Activity)

Hormones
Upright: 0.5-4.0 ng/mL/hr | Supine: 0.2-2.3 ng/mL/hr

Renin is released by kidney juxtaglomerular cells in response to low blood pressure, low sodium, or sympathetic stimulation. It converts angiotensinogen to angiotensin I, initiating the RAAS cascade. Renin measurement helps classify hypertension causes.

Clinical Significance

Low renin + high aldosterone: primary aldosteronism. High renin + high aldosterone: secondary (renovascular, diuretics). Low renin + low aldosterone: mineralocorticoid excess (Liddle syndrome, AME). Many drugs affect levels—careful preparation required.

17-OH Progesterone

Hormones
AM: <200 ng/dL (adult) | Varies by age and sex

17-hydroxyprogesterone is a precursor in cortisol and androgen synthesis. Elevated levels indicate 21-hydroxylase deficiency (most common cause of congenital adrenal hyperplasia, CAH). Used in newborn screening and evaluating hirsutism/PCOS for nonclassic CAH.

Clinical Significance

Very high 17-OHP (>1000 ng/dL): classic CAH—salt-wasting crisis in infancy. Moderately elevated (200-1000): nonclassic CAH (late-onset)—presents with hirsutism, acne, infertility. ACTH stimulation test confirms diagnosis if baseline borderline.

Androstenedione

Hormones
Women: 35-250 ng/dL | Men: 40-150 ng/dL

Androstenedione is an androgen precursor produced by adrenal glands and gonads, converted to testosterone and estrogen peripherally. Elevated in women with hyperandrogenism. Helps distinguish ovarian from adrenal androgen excess.

Clinical Significance

Elevated androstenedione with normal DHEA-S suggests ovarian source (PCOS, tumor). Elevated with high DHEA-S suggests adrenal source. Very high levels (>1000 ng/dL) suggest androgen-secreting tumor—requires imaging. Part of hirsutism/virilization workup.

Zinc

Vitamins
Normal: 60-120 μg/dL

Zinc is essential for enzyme function, immune response, wound healing, and taste/smell. Deficiency is common in malnutrition, malabsorption, chronic illness, and alcoholism. Serum zinc is not always reliable as it's a negative acute phase reactant.

Clinical Significance

Zinc deficiency: diarrhea, alopecia, dermatitis (acrodermatitis), impaired taste/smell, poor wound healing, immune dysfunction. Acrodermatitis enteropathica is severe inherited zinc deficiency. Test early morning, fasting. Inflammation lowers levels regardless of status.

Vitamin B1 (Thiamine)

Vitamins
Normal: 70-180 nmol/L (whole blood)

Thiamine is essential for carbohydrate metabolism and nerve function. Deficiency causes beriberi (cardiac/neurologic) and Wernicke-Korsakoff syndrome in alcoholics. Always give thiamine BEFORE glucose in suspected deficiency to prevent precipitating Wernicke's.

Clinical Significance

Deficiency: alcoholism, malnutrition, bariatric surgery, dialysis, prolonged TPN without supplementation. Wet beriberi: high-output heart failure. Dry beriberi: peripheral neuropathy. Wernicke triad: confusion, ataxia, ophthalmoplegia. Treat empirically—don't wait for labs.

Vitamin C (Ascorbic Acid)

Vitamins
Normal: 0.4-2.0 mg/dL

Vitamin C is essential for collagen synthesis, antioxidant function, and iron absorption. Humans cannot synthesize it (unlike most mammals). Deficiency causes scurvy with impaired wound healing, gum disease, and hemorrhage. Rare in developed countries except alcoholics and restricted diets.

Clinical Significance

Scurvy: perifollicular hemorrhages, gum bleeding/swelling, poor wound healing, anemia, fatigue. Risk groups: alcoholism, elderly, food insecurity, psychiatric disorders affecting diet. Responds rapidly to supplementation—improvement within days.

Vitamin K

Vitamins
Normal: 0.2-3.2 ng/mL

Vitamin K is essential for synthesizing clotting factors II, VII, IX, X and proteins C and S. Obtained from leafy greens (K1) and gut bacteria (K2). Deficiency causes coagulopathy with elevated PT/INR. Newborns are deficient—prophylactic vitamin K at birth prevents hemorrhagic disease.

Clinical Significance

Deficiency: malabsorption, prolonged antibiotics (kill gut flora), obstructive jaundice (bile needed for absorption), warfarin. PT responds to vitamin K in deficiency but not liver failure. 1 mg vitamin K can reverse warfarin in 24 hours—interferes with anticoagulation.

Peer-Reviewed Research & Publications

Our blood test biomarker analysis methodology is backed by peer-reviewed research published on ResearchGate and indexed with DOI numbers. These publications document our clinical validation framework, AI accuracy metrics, and global health insights.

Clinical Validation Framework for AI-Powered Blood Test Interpretation

Methodology Validation DOI: 10.5281/zenodo.17993721

Triple-blind validation methodology documenting how Kantesti AI achieves 99.84% accuracy in blood test interpretation, including performance metrics and quality assurance protocols.

Clinical Validation of AI-Powered RDW Interpretation: Multi-Parameter Neural Network Approach

RDW Neural Network DOI: 10.5281/zenodo.18202598

Detailed analysis of how our 2.78 trillion parameter neural network interprets Red Cell Distribution Width (RDW) with enhanced diagnostic accuracy for anemia classification.

Global Health Intelligence Report: AI Analysis of 25 Million Blood Tests Across 10 Countries

Global Health 2026 Report DOI: 10.5281/zenodo.18175532

Comprehensive analysis of blood test patterns from 25 million results revealing critical health trends, biomarker distributions, and population health insights across multiple countries.

Real Results from Real Users

See how healthcare providers and patients worldwide use Kantesti AI to transform blood test interpretation. Our case studies demonstrate practical applications across clinical settings, personal health monitoring, and medical research.

2M+Users Worldwide
127+Countries
98.7%User Satisfaction
Explore Case Studies & Success Stories
Trusted Health References

The biomarker information in this guide aligns with standards and guidelines from these authoritative health organizations:

Ready to Understand Your Blood Test Results?

Upload your blood test and get instant, comprehensive AI-powered analysis of all your biomarkers. Trusted by 2 million+ users in 127+ countries.

en_USEnglish